skin disease: Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.
Other and unspecified disorders of skin and subcutaneous tissue
DOID EFO Endpoint Browser PheWeb
L12_SKINSUBCUTISNAS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2519 |
4. Check minimum number of eventsNone |
2519 |
5. Include endpointsNone |
2519 |
6. Filter based on genotype QC (FinnGen only) |
2519 |
Control definitions (FinnGen only)
- Control exclude
- L12_OTHERSKINSUBCUTIS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified disorders of skin and subcutaneous tissue
based on the number of shared cases.
Similar with more cases:
- Other disorders of skin and subcutaneous tissue, not elsewhere classified
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 14996 | 8917 | 5967 |
| Only index persons | 12956 | 7849 | 5107 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.22 | 0.26 | 0.17 |
| Only index persons | 0.25 | 0.29 | 0.19 |
| Median age at first event (years) | |||
| Whole population | 51.34 | 52.02 | 50.23 |
| Only index persons | 49.71 | 50.36 | 48.71 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2519 | 1570 | 949 |
| Unadjusted period prevalence (%) | 0.49 | 0.54 | 0.42 |
| Median age at first event (years) | 53.97 | 51.84 | 57.49 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2337
- Matched controls
- 23370
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
6431.5
323.0
1840
13
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
7.6
220.4
571
948
L98.88
ICD-10 Finland
Other specified disorders of skin and subcutaneous tissue
120.9
176.1
189
17
70908
ICD-8 Finland
Other diseases of skin, Alii definiti
+∞
123.0
117
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
111.2
1266
7135
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
4.3
95.3
396
1062
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.8
93.6
748
3313
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.6
92.7
482
1571
E000001
ATC
NA
2.9
89.8
668
2811
E0000UV
ATC
NA
2.5
88.5
1101
6224
TQW99
NOMESCO Finland
Other minor procedure on skin
5.8
87.1
264
501
XQ802
NOMESCO Finland
Epicutan test
6.4
83.7
233
396
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.4
80.4
316
795
XQ800
NOMESCO Finland
Prick test
4.4
78.8
314
800
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.5
78.7
303
746
70909
ICD-8 Finland
Other diseases of skin, Unspecified
+∞
77.5
74
*
D07AC01
ATC
betamethasone; topical
2.2
66.8
910
5162
H25.8
ICD-10 Finland
Other senile cataract
3.2
66.3
388
1353
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.7
65.6
532
2296
H02AB04
ATC
methylprednisolone; systemic
2.8
65.3
486
1991
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
5.0
65.3
223
481
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
14.8
64.0
109
77
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
63.7
470
1911
D07AC13
ATC
mometasone; topical
2.3
62.4
789
4287
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
33.5
61.8
81
25
J01MA12
ATC
levofloxacin; systemic
2.6
61.6
549
2489
J01FF01
ATC
clindamycin; systemic
2.3
61.3
740
3926
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
60.8
615
2987
D07AD01
ATC
clobetasol; topical
2.7
59.9
463
1928
SPAT1263
SPAT
Sampling
2.1
59.4
1118
7191
H02AB06
ATC
prednisolone; systemic
2.0
58.7
1190
7873
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.5
57.9
525
2393
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.1
57.4
1033
6491
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
55.7
895
5345
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.8
55.6
407
1634
L57.0
ICD-10 Finland
Actinic keratosis
3.2
55.4
322
1108
XG410
NOMESCO Finland
Flow-volume spirometry
4.9
54.6
188
408
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.7
52.9
248
721
SPAT1216
SPAT
Assessment of functional ability
2.5
52.5
474
2140
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
50.2
766
4430
SPAT1153
SPAT
Removal of sutures
2.0
49.8
843
5085
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
48.8
392
1653
NF1AA
NOMESCO Finland
Hip X-ray examination
3.1
48.1
296
1054
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
47.3
774
4580
UJF30
NOMESCO Finland
Ileoscopy through colon
2.9
47.3
313
1168
SPAT1254
SPAT
Administration of medicine
2.5
47.1
433
1965
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.5
45.9
408
1816
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.4
45.5
142
275
S18
ICPC
Laceration/cut
1.9
45.1
1029
6871
SPAT1211
SPAT
Application of soft bandage
3.0
45.0
293
1082
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
6.7
44.7
117
181
H02AB07
ATC
prednisone; oral
2.4
44.5
418
1912
ZXE00
NOMESCO Finland
One hour or less
0.5
44.4
347
6461
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
3.5
43.9
218
662
L04AA06
ATC
mycophenolic acid; systemic
9.3
43.8
93
104
SPAT1310
SPAT
Counselling related to known health issue
1.9
43.6
817
5061
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
5.8
42.6
125
225
ZXD10
NOMESCO Finland
Scheduled procedure
0.5
40.9
360
6480
7099X
ICD-9 Finland
Other disorders of skin and subcutaneous tissue, Unspecified disorder of skin and subcutaneous tissue
+∞
40.7
39
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.5
40.7
345
1489
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
40.3
425
2053
7098X
ICD-9 Finland
Other disorders of skin and subcutaneous tissue, Other specified disorders of skin[MORBI CUTIS ET SUBCUTIS ALIA DEFINITA]
+∞
39.7
38
*
C03CA01
ATC
furosemide; systemic
2.0
39.7
686
4091
AA1AD
NOMESCO Finland
CT of head and brain
2.0
39.3
612
3502
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
4.8
39.1
135
293
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.4
38.9
359
1617
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
38.8
458
2328
127
Kela drug reimbursment
Transplant complication
9.0
38.1
82
94
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.4
37.9
197
618
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
4.4
37.9
143
340
WQ021
NOMESCO Finland
NA
40.0
37.6
47
12
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.8
37.3
1008
6976
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.6
36.8
133
303
Z00.0
ICD-10 Finland
General medical examination
2.1
36.5
488
2612
Z04.3
ICD-10 Finland
Examination and observation following other accident
6.0
35.5
101
175
J01DB01
ATC
cefalexin; oral
1.9
35.1
1879
15974
Z01.2
ICD-10 Finland
Dental examination
1.8
34.6
963
6673
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
4.3
34.5
133
323
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.2
34.4
136
338
S97
ICPC
Chronic ulcer skin
3.8
34.4
151
413
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
34.3
297
1289
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.0
34.3
217
782
D02AE01
ATC
carbamide; topical
3.1
34.3
205
710
N03AX16
ATC
pregabalin; oral
1.9
34.2
573
3344
Z2221
NOMESCO Finland
Medical doctor
0.4
34.2
209
4305
A02BC02
ATC
pantoprazole; systemic
1.7
33.2
1503
11972
Z94.0
ICD-10 Finland
Kidney transplant status
12.0
33.2
61
52
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.4
31.8
85
136
L04AX01
ATC
azathioprine; systemic
3.8
31.6
142
396
UKC02
NOMESCO Finland
Cystoscopy
2.1
31.4
396
2052
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.5
31.3
156
473
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
31.3
1151
8573
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.6
30.7
145
422
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.5
30.6
271
1186
N02AX02
ATC
tramadol; systemic, rectal
1.7
30.5
961
6832
ZXC50
NOMESCO Finland
Cryotherapy
4.7
30.3
106
234
L04AA01
ATC
[U] ciclosporin; systemic
8.0
30.2
69
88
R06AE07
ATC
cetirizine; oral
1.7
29.8
994
7166
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.3
29.8
161
519
NG2AA
NOMESCO Finland
Patella X-ray examination
4.5
29.8
108
247
QBJ30
NOMESCO Finland
Correction of abdominal apron
14.6
29.7
50
35
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
5.6
29.7
89
165
L04AD01
ATC
ciclosporin; systemic
6.5
29.2
77
121
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.3
29.2
297
1393
ZXE10
NOMESCO Finland
More than one and less than three hours
0.5
29.0
361
5980
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
29.0
524
3114
D82
ICPC
Teeth/gum disease
1.7
28.9
781
5289
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
28.8
163
542
L93.0
ICD-10 Finland
Discoid lupus erythematosus
151.9
28.7
30
*
M05BA04
ATC
alendronic acid; oral
2.5
28.7
234
980
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.5
28.6
237
1002
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
11.3
28.1
53
48
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
28.0
770
5227
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.2
27.8
298
1432
N02AA05
ATC
oxycodone; systemic
2.1
27.7
355
1846
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
2.8
27.5
189
714
L89
ICD-10 Finland
Decubitus ulcer and pressure area
19.8
27.4
41
21
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.0
27.3
383
2065
A46
ICD-10 Finland
Erysipelas
2.1
27.0
327
1657
L28
ICPC
Limited function/disability (L)
2.0
27.0
390
2127
SPAT1172
SPAT
Guidance concerning hydration
4.8
27.0
92
198
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.4
26.9
237
1033
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
4.4
26.9
100
235
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.5
26.7
96
218
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
26.7
200
798
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
6.5
26.6
70
110
SPAT1312
SPAT
General health counselling
1.7
26.6
750
5109
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
26.6
261
1200
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
26.5
642
4179
M01AE02
ATC
naproxen; oral, rectal
1.6
26.5
1281
10075
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.0
26.3
160
558
WX722
NOMESCO Finland
PEEP
3.2
26.1
147
486
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
25.8
223
962
N02BE01
ATC
paracetamol; systemic, rectal
1.8
25.7
1964
17406
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
5.1
25.7
82
164
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
25.7
203
834
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.6
25.6
76
140
70198
ICD-8 Finland
Other hypertrophic and atrophic conditions of the skin, Alii definiti
+∞
25.0
24
*
SPAT1262
SPAT
Handing over of treatment supplies
1.9
24.8
436
2552
D07CC01
ATC
betamethasone and antibiotics; topical
2.1
24.7
315
1628
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
12.1
24.7
45
38
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
4.1
24.7
98
245
WQ007
NOMESCO Finland
NA
27.9
24.5
33
12
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
24.4
221
973
137
Kela drug reimbursment
Uraemia requiring dialysis
11.1
24.4
46
42
J01DA01
ATC
[U] cefalexin; systemic
1.6
24.3
1411
11493
TQW80
NOMESCO Finland
Local dermatologic skincare
4.7
24.3
84
184
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
4.1
24.2
96
240
JN4AD
NOMESCO Finland
Body CT examination
2.5
24.1
200
843
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.9
24.1
153
550
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
3.1
24.1
138
464
L03
ICPC
Low back symptom/complaint
1.7
24.0
557
3562
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.6
24.0
184
744
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
23.8
255
1223
D07AB08
ATC
desonide; topical
2.2
23.6
255
1225
ZZA00
NOMESCO Finland
Split skin graft
4.4
23.5
87
204
V03AE01
ATC
polystyrene sulfonate; oral
7.2
23.4
57
81
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
16.3
23.2
37
23
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
7.4
23.0
55
76
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
4.2
22.9
88
214
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.5
22.9
183
757
R06.0
ICD-10 Finland
Dyspnoea
1.7
22.7
547
3528
J02AC01
ATC
fluconazole; systemic
1.6
22.7
881
6468
PC6DE
NOMESCO Finland
NA
232.2
22.7
23
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.6
22.4
168
670
G47.3
ICD-10 Finland
Sleep apnoea
1.8
22.2
455
2788
XF640
NOMESCO Finland
NA
3.8
22.2
95
255
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
11.6
22.2
41
36
N06AA09
ATC
amitriptyline; systemic
2.2
22.2
253
1246
SPAT1229
SPAT
Assessment of need for aid
2.3
22.1
215
983
SPAT1234
SPAT
Support of social functional capacity
2.8
22.1
146
539
A02BC05
ATC
esomeprazole; systemic
1.6
22.0
914
6808
P01BA02
ATC
hydroxychloroquine; oral
2.3
21.9
218
1007
TGC00
NOMESCO Finland
Bronchial lavation
4.1
21.9
86
214
L82
ICD-10 Finland
Seborrhoeic keratosis
2.0
21.9
323
1767
A12AA04
ATC
calcium carbonate; oral
6.1
21.7
59
98
B07.9
ICD-10 Finland
Verruca simplex
3.8
21.6
94
256
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.3
21.6
52
73
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
21.4
151
582
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.7
21.2
94
260
D07BC01
ATC
betamethasone and antiseptics; topical
2.0
21.2
281
1472
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.9
21.0
88
232
L13
ICPC
Hip symptom/complaint
1.8
21.0
383
2256
J01MA02
ATC
ciprofloxacin; systemic
1.6
21.0
853
6301
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.7
21.0
93
258
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
20.9
642
4418
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
19.6
20.8
31
16
V03AE02
ATC
sevelamer; oral
15.0
20.7
34
23
J01MA01
ATC
ofloxacin; systemic
2.2
20.6
221
1054
Z49.0
ICD-10 Finland
Preparatory care for dialysis
9.5
20.6
42
45
D06BB10
ATC
imiquimod; topical
2.9
20.5
132
478
L30.3
ICD-10 Finland
Infective dermatitis
3.5
20.5
97
284
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
2.9
20.5
132
479
TQW11
NOMESCO Finland
Vacuum treatment of wound
5.4
20.4
62
118
L91.0
ICD-10 Finland
Hypertrophic scar
25.7
20.4
28
11
R50.9
ICD-10 Finland
Fever, unspecified
1.9
20.4
315
1747
M79.1
ICD-10 Finland
Myalgia
2.0
20.3
301
1646
WX202
NOMESCO Finland
Supraclavicular plexus blockade
5.7
20.3
58
103
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
20.2
908
6850
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
20.1
769
5581
L50.8
ICD-10 Finland
Other urticaria
5.2
20.0
63
125
K03.66
ICD-10 Finland
Tooth plaque
2.4
20.0
171
732
TQW40
NOMESCO Finland
Remowal of suture of skin
2.4
20.0
179
783
B05DA
ATC
Isotonic solutions
11.4
19.9
37
33
N05BA04
ATC
oxazepam; oral
1.7
19.9
542
3604
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
19.9
509
3325
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
8.9
19.9
42
48
7019X
ICD-9 Finland
Other hypertrophic and atrophic conditions of skin, Unspecified hypertrophic and atrophic conditions of skin[HYPERTROPHIA SEU ATROPHIA CUTIS NUD]
+∞
19.8
19
*
SPAT1104
SPAT
Monitoring of emergency patient
2.3
19.8
187
843
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.7
19.8
89
250
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
19.7
217
1049
J01AA04
ATC
lymecycline; systemic
1.9
19.7
295
1619
L17
ICPC
Foot/toe symptom/complaint
1.6
19.6
553
3710
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.1
19.5
111
372
A07AA02
ATC
nystatin; oral
2.5
19.4
159
667
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
3.8
19.4
82
219
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
13.4
19.2
33
25
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
19.2
592
4065
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.7
19.0
136
528
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
5.6
18.9
55
100
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
9.2
18.9
39
43
R01AD08
ATC
fluticasone; nasal
1.6
18.8
623
4352
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.1
18.8
224
1121
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
18.8
199
945
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
18.7
1160
9338
D07CB01
ATC
triamcinolone and antibiotics; topical
4.1
18.6
74
187
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
9.4
18.6
38
41
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.8
18.5
79
213
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.6
18.4
503
3339
D07XC01
ATC
betamethasone, combinations; topical
1.9
18.3
275
1508
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
30.3
18.3
24
8
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
7.2
18.3
44
62
E66.01
ICD-10 Finland
Obesity due to excess calories
2.3
18.3
181
834
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
9.0
18.1
38
43
M04AA01
ATC
allopurinol; systemic
1.9
18.1
273
1498
R32
ICD-10 Finland
Unspecified urinary incontinence
3.3
18.1
93
291
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
2.1
18.1
227
1160
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.2
18.0
95
303
WQ020
NOMESCO Finland
NA
33.2
18.0
23
7
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
17.9
228
1171
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.7
17.9
125
477
NA3CF
NOMESCO Finland
Lumbar spine extensive MRI examination with median intensity magnet
11.1
17.7
33
30
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
3.4
17.7
88
269
WZC30
NOMESCO Finland
Teaching
1.8
17.6
304
1752
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.1
17.6
207
1029
E000006
ATC
NA
2.2
17.6
179
834
CS494
NOMESCO Finland
Other visual field testing
3.8
17.6
76
207
ZXD40
NOMESCO Finland
Procedure on patient requiring isolation
15.7
17.5
28
18
I78.1
ICD-10 Finland
Naevus, non-neoplastic
3.7
17.3
77
215
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
24.2
17.3
24
10
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
17.3
240
1278
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
42.3
17.3
21
5
S77
ICPC
Malignant neoplasm of skin
5.6
17.2
50
91
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.1
17.2
94
308
DFF00
NOMESCO Finland
Pure tone audiometry
2.0
17.1
218
1121
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.5
16.9
828
6296
A11CC03
ATC
alfacalcidol; systemic
4.0
16.8
68
175
FN1AD
NOMESCO Finland
CT of coronary arteries
5.0
16.7
53
107
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.5
16.7
39
53
H26.3
ICD-10 Finland
Drug-induced cataract
9.8
16.6
33
34
M02AA10
ATC
ketoprofen; topical
1.7
16.6
359
2224
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
4.9
16.5
54
113
E0001A1
ATC
NA
4.0
16.4
66
169
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
16.4
458
3047
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.4
16.4
142
613
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
16.3
185
908
R4110
NOMESCO Finland
Physiotherapy
0.6
16.2
248
3982
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
4.6
16.2
56
124
X58
ICD-10 Finland
Exposure to other specified factors
1.8
16.1
291
1700
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
47.8
16.0
19
*
L92.0
ICD-10 Finland
Granuloma annulare
47.8
16.0
19
*
SPAT1301
SPAT
No procedures
1.5
16.0
682
5017
NF1DA
NOMESCO Finland
X-ray of hips
3.7
15.9
69
189
B05DB
ATC
Hypertonic solutions
10.1
15.9
31
31
J01CA04
ATC
amoxicillin; systemic
1.5
15.9
1758
15650
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.8
15.9
275
1583
J05AB01
ATC
aciclovir; systemic
1.6
15.9
464
3116
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
15.9
854
6595
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
15.9
219
1163
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
15.8
174
841
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.9
15.8
242
1336
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.5
15.8
763
5763
WX110
NOMESCO Finland
Local anesthesy
1.4
15.8
1447
12396
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
15.7
316
1912
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
8.8
15.7
33
38
NHQ40
NOMESCO Finland
Amputation of toe
6.5
15.7
40
62
R60.0
ICD-10 Finland
Localized oedema
1.9
15.6
244
1356
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.8
15.6
104
388
L16
ICPC
Ankle symptom/complaint
1.9
15.5
234
1285
N18.0
ICD-10 Finland
End-stage renal disease
6.4
15.5
40
63
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
4.8
15.5
51
108
S29
ICPC
Skin symptom/complaint other
1.7
15.4
367
2329
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
15.4
512
3551
TK800
NOMESCO Finland
Hemodialysis
4.1
15.4
59
145
J02AC02
ATC
itraconazole; systemic
1.7
15.4
394
2554
M25.5
ICD-10 Finland
Pain in joint
1.5
15.2
593
4265
D05BB02
ATC
acitretin; oral
3.6
15.2
68
192
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
3.6
15.1
68
193
K02.1
ICD-10 Finland
Caries of dentine
1.4
15.0
1157
9547
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
15.0
173
855
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.4
14.9
71
211
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
15.1
14.9
24
16
L43.8
ICD-10 Finland
Other lichen planus
4.1
14.8
57
141
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
14.8
1464
12638
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
14.8
222
1215
PC5DE
NOMESCO Finland
Ultrasound of kidney circulation with Doppler technic
10.5
14.7
28
27
XQ818
NOMESCO Finland
Conjunctival allergen provocation test
25.2
14.7
20
8
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.7
14.7
298
1804
N03AX12
ATC
gabapentin; oral
1.7
14.6
330
2062
L01
ICPC
Neck symptom/complaint
1.7
14.6
298
1807
R03AC02
ATC
salbutamol; inhalant
1.4
14.5
1099
9014
Z49.2
ICD-10 Finland
Other dialysis
8.9
14.4
30
34
SPAT1325
SPAT
Vaccination
1.5
14.4
749
5717
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
10.1
14.4
28
28
PH2CD
NOMESCO Finland
Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity
7.9
14.3
32
41
SPAT1260
SPAT
Consultation of another employee
1.6
14.3
386
2536
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
4.7
14.3
48
104
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
14.3
156
750
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
10.5
14.2
27
26
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.2
14.2
144
672
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
14.1
343
2191
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
5.5
14.0
41
76
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
5.5
14.0
41
76
A99
ICPC
Disease/condition unspecnature/site
2.0
14.0
181
936
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
14.0
565
4084
J37.0
ICD-10 Finland
Chronic laryngitis
2.8
14.0
90
328
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.0
14.0
178
914
R42
ICD-10 Finland
Dizziness and giddiness
1.6
13.9
467
3236
A02BC04
ATC
rabeprazole; oral
2.0
13.9
196
1047
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.4
13.9
954
7668
M79.6
ICD-10 Finland
Pain in limb
1.4
13.9
742
5684
L15
ICPC
Knee symptom/complaint
1.6
13.9
451
3103
B03XA02
ATC
darbepoetin alfa; parenteral
4.1
13.8
53
131
L84
ICD-10 Finland
Corns and callosities
3.3
13.8
69
213
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
8.2
13.8
30
37
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
13.8
1325
11303
Z42.0
ICD-10 Finland
Follow-up care involving plastic surgery of head and neck
20.2
13.8
20
10
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
13.8
166
835
SPAT1311
SPAT
Counselling and guidance related to occupational health
2.9
13.7
81
281
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
8.6
13.7
29
34
D06BX01
ATC
metronidazole; topical
1.8
13.7
232
1325
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
13.7
226
1277
UJF32
NOMESCO Finland
Coloscopy
1.5
13.7
544
3917
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
13.7
783
6078
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.4
13.5
112
471
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.3
13.5
132
605
E66.8
ICD-10 Finland
Other obesity
2.4
13.5
113
480
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
7.2
13.5
32
45
K13.78
ICD-10 Finland
Other change in the oral mucosa
3.5
13.5
62
180
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.0
13.4
172
885
L08
ICPC
Shoulder symptom/complaint
1.6
13.4
403
2719
R03BA05
ATC
fluticasone; inhalant
1.6
13.4
394
2644
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
13.3
126
570
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.2
13.3
143
685
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
13.3
980
7956
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.3
13.3
65
198
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
10.5
13.2
25
24
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
9.7
13.2
26
27
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
13.2
577
4236
NK6AN
NOMESCO Finland
Total body bone isotope imaging
2.8
13.2
82
295
SPAT1255
SPAT
Intravenous administration of medicine
2.1
13.1
150
737
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
3.8
13.1
55
148
D01AE16
ATC
amorolfine; topical
1.8
13.0
255
1527
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.9
12.9
52
135
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
4.5
12.9
45
102
M54.5
ICD-10 Finland
Low back pain
1.4
12.9
663
5029
N03AE01
ATC
clonazepam; systemic
2.2
12.9
133
627
ZSN00
NOMESCO Finland
Procedure related to previous procedure classified in chapter N
7.7
12.9
29
38
UJC12
NOMESCO Finland
Flexible oesophagoscopy
7.0
12.9
31
45
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
12.9
1078
8935
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
5.1
12.7
39
77
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
12.7
947
7685
R06AX22
ATC
ebastine; oral
1.6
12.7
353
2333
S99
ICPC
Skin disease other
3.5
12.6
58
169
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
6.2
12.6
33
54
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.1
12.6
67
218
L20.0
ICD-10 Finland
Besnier prurigo
2.2
12.6
130
613
JN6AD
NOMESCO Finland
CT of torso and neck
4.8
12.5
41
87
L98.80
ICD-10 Finland
Hereditary mucoepithelial dysplasia
+∞
12.5
12
*
WX320
NOMESCO Finland
Spinalanesthesy
1.5
12.5
470
3337
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.3
12.5
63
197
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
10.1
12.5
24
24
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.5
12.5
500
3600
DAX08
NOMESCO Finland
Fitting of hearing aid
2.4
12.5
108
466
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
12.4
255
1548
J01FA10
ATC
azithromycin; systemic
1.4
12.4
1201
10170
R06AE09
ATC
levocetirizine; oral
1.7
12.3
280
1750
PA7BD
NOMESCO Finland
CT angiography of neck and brain
3.7
12.3
53
146
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
12.3
615
4626
196
Kela drug reimbursment
Paricalcitol and cinacalcet
11.7
12.3
22
19
J01MA14
ATC
moxifloxacin; systemic
1.9
12.3
191
1059
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
12.3
324
2110
R51.80
ICD-10 Finland
Headache
1.7
12.3
290
1831
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.5
12.3
535
3917
D05AX52
ATC
calcipotriol, combinations; topical
2.3
12.3
116
526
SPAT1360
SPAT
Extensive global examination
1.9
12.3
173
925
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
10.5
12.2
23
22
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
6.0
12.2
33
56
ZXC15
NOMESCO Finland
Use of photodynamic technique
4.5
12.2
42
94
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
4.9
12.2
39
81
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
2.3
12.2
109
479
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
3.2
12.2
63
201
GD2SN
NOMESCO Finland
Lung ventilation SPECT
6.4
12.1
31
49
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
12.1
232
1376
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
3.2
12.1
62
196
J01AA02
ATC
doxycycline; systemic
1.4
12.1
1696
15261
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.8
12.0
212
1226
XQ817
NOMESCO Finland
NA
21.4
12.0
17
8
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
10.1
12.0
23
23
N05BB01
ATC
hydroxyzine; systemic
2.1
12.0
140
697
ULC02
NOMESCO Finland
Hysteroscopy
2.2
11.9
123
577
9733
FHL
Excision of skin change in operating room or anesthesia
4.2
11.9
44
106
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
11.9
362
2443
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
2.0
11.8
156
814
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
3.9
11.8
48
126
TK810
NOMESCO Finland
Hemofiltration
7.1
11.8
28
40
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
11.8
740
5803
NK4EA
NOMESCO Finland
Joint X-ray examintion with load or wrench not elsewhere classified
5.5
11.8
34
63
P01AB01
ATC
metronidazole; oral, rectal
1.4
11.8
814
6495
WX402
NOMESCO Finland
General anaesthesia
0.5
11.8
124
2209
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.3
11.8
109
487
D06BX02
ATC
ingenol mebutate; topical
4.0
11.8
46
117
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.1
11.7
140
700
GD1UN
NOMESCO Finland
Lung circulation SPECT
7.4
11.7
27
37
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.1
11.7
64
213
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.2
11.7
119
558
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
11.7
248
1522
GD1AD
NOMESCO Finland
Thorax CT examination
2.4
11.7
100
430
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.1
11.6
133
655
L50.9
ICD-10 Finland
Urticaria, unspecified
2.6
11.6
82
319
A06AD11
ATC
lactulose; oral
1.6
11.6
296
1912
E66.00
ICD-10 Finland
Metabolic syndrome
2.2
11.6
113
518
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.5
11.5
91
377
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
8.6
11.5
24
28
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.5
11.5
93
388
J20
ICD-10 Finland
Acute bronchitis
1.8
11.5
204
1184
WQ026
NOMESCO Finland
NA
120.6
11.4
12
*
P01BA01
ATC
chloroquine; systemic
7.5
11.4
26
35
CKW99
NOMESCO Finland
Other operation on choroid, vitreous body and retina
7.5
11.4
26
35
R03BA08
ATC
ciclesonide; inhalant
1.9
11.4
170
929
A03
ICPC
Fever
1.6
11.4
298
1934
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
2.0
11.3
140
714
WZA90
NOMESCO Finland
Other doctors statement
1.5
11.3
458
3297
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.6
11.3
288
1857
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.9
11.3
177
986
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
9.6
11.2
22
23
S01AA02
ATC
chlortetracycline; ophthalmic
6.2
11.2
29
47
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.5
11.2
83
333
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
5.5
11.2
32
59
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.7
11.2
215
1279
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.4
11.2
94
401
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.8
11.2
70
254
D05AX02
ATC
calcipotriol; topical
2.4
11.1
91
383
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
3.3
11.1
54
165
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.4
11.1
92
392
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.1
11.1
127
628
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
3.8
11.1
46
124
N06AB04
ATC
citalopram; systemic
1.5
11.0
438
3137
HA1AA
NOMESCO Finland
X-ray mammography
1.9
11.0
173
962
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
7.1
11.0
26
37
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.5
11.0
50
145
S76
ICPC
Skin infection other
2.2
10.9
111
518
ZXD20
NOMESCO Finland
Day surgery
0.5
10.9
88
1696
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
10.9
1143
9720
B01AF01
ATC
rivaroxaban; oral
1.7
10.8
256
1616
A01AB09
ATC
miconazole; local oral
1.8
10.8
186
1066
D01BA02
ATC
terbinafine; oral; topical
1.5
10.8
496
3658
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.8
10.8
189
1091
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
10.8
354
2428
L21.0
ICD-10 Finland
Seborrhoea capitis
5.1
10.8
33
66
FM1TQ
NOMESCO Finland
Heart perfusion SPECT with low dose CT at rest and with exercise
10.6
10.8
20
19
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
10.7
508
3769
Z42.4
ICD-10 Finland
Follow-up care involving plastic surgery of lower extremity
28.1
10.7
14
5
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
4.1
10.7
40
98
R06.2
ICD-10 Finland
Wheezing
2.3
10.7
98
439
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
21.6
10.7
15
7
R11
ICD-10 Finland
Nausea and vomiting
1.9
10.7
166
920
DFF59
NOMESCO Finland
Other assessment of balance
4.6
10.7
36
80
R35
ICD-10 Finland
Polyuria
2.0
10.6
132
672
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
12.9
10.6
18
14
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
60.3
10.6
12
*
7151
FHL
Kidney transplantation
60.3
10.6
12
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
2.0
10.6
142
744
B03XA01
ATC
erythropoietin; parenteral
6.0
10.6
28
47
R01AD09
ATC
mometasone; nasal
1.4
10.5
895
7352
J04BA02
ATC
dapsone; oral
11.3
10.5
19
17
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
10.5
231
1430
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.1
10.5
57
189
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
10.5
197
1163
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
4.4
10.5
37
86
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
0.3
10.5
19
664
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.9
10.4
155
847
L95.8
ICD-10 Finland
Other vasculitis limited to skin
+∞
10.4
10
*
5602
FHL
Internal fistula (eg Cimino)
+∞
10.4
10
*
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.6
10.4
270
1746
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.6
10.4
313
2103
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
10.4
229
1419
E000002
ATC
NA
1.7
10.4
226
1397
P20
ICPC
Memory disturbance
1.7
10.4
242
1525
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
10.3
552
4188
DFF15
NOMESCO Finland
Speech audiometry
2.2
10.3
103
481
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.1
10.3
55
181
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
10.3
244
1542
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.9
10.3
61
215
QAJ10
NOMESCO Finland
Browlift
8.8
10.3
21
24
M86.6
ICD-10 Finland
Other chronic osteomyelitis
18.9
10.3
15
8
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.9
10.2
149
808
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
3.1
10.2
53
171
Z3226
NOMESCO Finland
Physiotherapist
0.6
10.2
165
2636
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
6.6
10.2
25
38
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.9
10.2
139
736
C01CA24
ATC
epinephrine; parenteral
2.0
10.2
127
651
D69.0
ICD-10 Finland
Allergic purpura
7.5
10.2
23
31
N30.0
ICD-10 Finland
Acute cystitis
1.6
10.2
290
1922
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
10.1
408
2927
SPAT1167
SPAT
Insertion of urinary catheter
2.6
10.1
72
284
WX199
NOMESCO Finland
Other local analgesia
2.8
10.0
64
236
L29.9
ICD-10 Finland
Pruritus, unspecified
2.9
10.0
59
207
M10.9
ICD-10 Finland
Gout, unspecified
2.0
10.0
125
640
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
3.8
10.0
41
110
D07XB01
ATC
flumetasone, combinations; topical
5.5
10.0
28
51
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
9.9
365
2566
A63.0
ICD-10 Finland
Anogenital (venereal) warts
2.5
9.9
75
306
M48.0
ICD-10 Finland
Spinal stenosis
1.6
9.9
248
1592
M03BX02
ATC
tizanidine; oral
1.3
9.8
1258
10953
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
9.8
255
1649
D02AX
ATC
Other emollients and protectives
2.6
9.8
71
282
NE1BA
NOMESCO Finland
Pelvis extensive X-ray examination
3.7
9.8
41
112
L76
ICPC
Fracture: other
2.7
9.8
66
251
S82
ICPC
Naevus/mole
1.6
9.8
253
1637
L01AA01
ATC
cyclophosphamide; systemic
10.7
9.8
18
17
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
9.8
151
836
TEA00
NOMESCO Finland
Biopsy of lip
4.5
9.7
33
74
C08CA05
ATC
nifedipine; systemic
1.9
9.7
138
743
EKA10
NOMESCO Finland
Biopsy of cheek
3.1
9.7
51
166
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
4.4
9.7
34
79
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.0
9.7
121
622
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.1
9.6
52
173
T89
ICPC
Diabetes insulin dependent
2.4
9.6
76
318
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
8.4
9.5
20
24
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.9
9.5
142
779
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
9.1
9.5
19
21
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
15.1
9.5
15
10
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.1
9.5
109
541
SPAT1053
SPAT
Memory test
1.5
9.5
300
2036
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
3.1
9.5
49
158
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
9.5
345
2421
WX882
NOMESCO Finland
High dependency care
2.6
9.5
65
251
J01CF05
ATC
flucloxacillin; systemic
2.5
9.5
74
305
L43.9
ICD-10 Finland
Lichen planus, unspecified
3.2
9.4
47
148
L98.0
ICD-10 Finland
Pyogenic granuloma
30.1
9.4
12
*
A02BA02
ATC
ranitidine; systemic
1.5
9.4
399
2890
L98.8
ICD-10 Finland
Other specified disorders of skin and subcutaneous tissue
+∞
9.4
9
*
J01MA06
ATC
norfloxacin; oral
1.6
9.4
283
1903
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
3.3
9.4
46
143
QBJ00
NOMESCO Finland
Liposuction in trunk
12.4
9.4
16
13
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
8.1
9.3
20
25
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.9
9.3
124
654
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.1
9.3
104
509
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
9.2
255
1676
N18.8
ICD-10 Finland
Other chronic renal failure
2.8
9.2
58
211
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.3
9.2
79
344
9862
FHL
Facial skin shaping surgery (Faclift)
13.7
9.2
15
11
V03AE03
ATC
lanthanum carbonate; oral
13.7
9.2
15
11
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
4.5
9.1
31
70
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
6.7
9.1
22
33
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
9.1
807
6633
L30.1
ICD-10 Finland
Dyshidrosis [pompholyx]
7.7
9.1
20
26
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
7.7
9.1
20
26
W19
ICD-10 Finland
Unspecified fall
1.7
9.1
181
1087
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
3.7
9.1
38
104
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
3.8
9.1
37
99
N05BA12
ATC
alprazolam; oral
1.7
9.1
204
1272
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.1
9.1
101
495
R02
ICPC
Shortness of breath/dyspnoea
1.6
9.1
235
1520
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
5.1
9.1
27
53
-50
ICPC
Medication/prescr/renewal
2.1
9.1
94
447
NC1BA
NOMESCO Finland
Elbow extensive X-ray examination
5.4
9.0
26
49
L01BB01
ATC
NA
15.6
9.0
14
9
D06BB04
ATC
podophyllotoxin; topical
2.2
9.0
93
439
D05AX03
ATC
calcitriol; topical
3.6
9.0
39
110
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
3.8
9.0
36
95
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.4
9.0
77
332
C10AC01
ATC
colestyramine; oral
2.7
9.0
61
233
PD5AD
NOMESCO Finland
CT of aorta
3.4
9.0
42
126
A04
ICPC
Weakness/tiredness general
1.6
9.0
257
1706
R06AX18
ATC
acrivastine; oral
2.5
9.0
66
266
R03AK08
ATC
formoterol and beclometasone; inhalant
2.3
9.0
77
334
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
6.5
8.9
22
34
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
8.9
406
2977
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.5
8.9
381
2761
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.6
8.9
253
1676
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.5
8.9
68
280
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
4.1
8.8
33
82
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
6.8
8.8
21
31
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
3.6
8.8
38
107
C07AB02
ATC
metoprolol; systemic
1.4
8.8
410
3019
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
8.8
452
3390
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
5.0
8.8
27
55
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.7
8.8
191
1177
JF2AD
NOMESCO Finland
Colon CT
9.5
8.8
17
18
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.5
8.8
67
275
A06AC51
ATC
ispaghula, combinations; systemic
2.0
8.7
107
544
K02.0
ICD-10 Finland
Caries limited to enamel
1.6
8.7
242
1593
JF2BD
NOMESCO Finland
Extensive colon CT
4.4
8.7
30
69
R78
ICPC
Acute bronchitis/bronchiolitis
2.7
8.7
59
225
WQ022
NOMESCO Finland
NA
50.2
8.7
10
*
SPAT1097
SPAT
Recording of ECG
1.5
8.7
302
2095
ZZR00
NOMESCO Finland
Flap of skin
2.8
8.7
52
186
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
8.7
421
3128
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
8.7
206
1304
K03.64
ICD-10 Finland
Dental calculus supragingival
1.4
8.6
527
4076
-48
ICPC
Clarification/discussion RFE/demand
2.6
8.6
59
227
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
7.7
8.6
19
25
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
7.7
8.6
19
25
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.4
8.6
69
289
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.2
8.6
81
369
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.2
8.6
83
381
R03DA05
ATC
aminophylline; systemic, rectal
5.0
8.6
26
52
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
8.6
520
4013
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.3
8.5
41
126
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
16.3
8.5
13
8
-34
ICPC
Blood test
2.5
8.5
66
273
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
2.9
8.5
50
176
H3600, E103
ICD-10 Finland
NA
4.3
8.5
30
71
WQ031
NOMESCO Finland
NA
27.6
8.5
11
*
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
2.3
8.5
75
333
L30.0
ICD-10 Finland
Nummular dermatitis
2.3
8.5
75
333
L52
ICD-10 Finland
Erythema nodosum
6.0
8.4
22
37
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.8
8.4
138
782
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.9
8.4
121
656
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
8.4
464
3528
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
8.4
326
2314
L98.6
ICD-10 Finland
Other infiltrative disorders of skin and subcutaneous tissue
+∞
8.3
8
*
QBG10
NOMESCO Finland
Excision and repair of bedsore of trunk
+∞
8.3
8
*
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
3.8
8.3
33
87
C03DA01
ATC
spironolactone; oral
1.6
8.3
204
1305
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
8.2
606
4827
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
4.0
8.2
31
78
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.6
8.2
57
222
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.0
8.2
101
514
ZZH31
NOMESCO Finland
Bone allograft, small pieces
4.8
8.2
26
55
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.4
8.2
67
285
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.3
8.2
73
325
L85.9
ICD-10 Finland
Epidermal thickening, unspecified
14.5
8.2
13
9
N04BC05
ATC
pramipexole; oral
1.8
8.2
145
844
KCV04
NOMESCO Finland
Distension of bladder with fluid
4.1
8.2
30
74
XQ899
NOMESCO Finland
Other assessment of skin
7.5
8.2
18
24
JN4CD
NOMESCO Finland
Very extensive body CT
2.1
8.1
87
419
J05AB11
ATC
valaciclovir; oral
1.5
8.1
259
1762
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
5.7
8.1
22
39
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.3
8.1
74
332
G04BD12
ATC
mirabegron; oral
1.6
8.1
205
1321
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
8.1
428
3227
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
11.7
8.1
14
12
H03AA01
ATC
levothyroxine sodium; systemic
1.4
8.1
479
3683
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
3.0
8.1
44
149
M05BX04
ATC
denosumab; parenteral
1.9
8.0
106
556
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
2.8
8.0
48
172
N05BA06
ATC
lorazepam; systemic, sublingual
1.9
8.0
106
557
C05AA08
ATC
fluocortolone; rectal, topical
1.5
8.0
286
1994
WX204
NOMESCO Finland
Axillary plexus blockaced
2.4
8.0
66
283
J01AA07
ATC
tetracycline; systemic
1.5
8.0
283
1967
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.1
8.0
88
428
N06AX11
ATC
mirtazapine; oral
1.3
8.0
610
4882
D01AC03
ATC
econazole; topical
1.9
8.0
123
681
B37.08
ICD-10 Finland
Other candidal stomatitis
5.5
8.0
22
40
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.5
8.0
59
239
N19
ICD-10 Finland
Unspecified kidney failure
2.4
8.0
65
277
NGQ20
NOMESCO Finland
Amputation of lower leg
7.2
8.0
18
25
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.0
7.9
30
76
SPAT1152
SPAT
Removal of foreign body from under the skin
2.5
7.9
59
240
R05FB02
ATC
cough suppressants and expectorants
1.3
7.9
770
6384
N05CF01
ATC
zopiclone; oral
1.3
7.9
634
5113
H02AB09
ATC
hydrocortisone; systemic
2.7
7.9
51
192
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
7.9
852
7167
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.1
7.8
83
400
SPAT1359
SPAT
Use of symptom diary
2.6
7.8
54
209
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
3.1
7.8
41
135
-42
ICPC
Electrical tracing
3.2
7.8
39
124
M02AA07
ATC
piroxicam; topical
1.3
7.8
736
6072
R05
ICD-10 Finland
Cough
1.4
7.8
378
2801
B35.3
ICD-10 Finland
Tinea pedis
2.2
7.8
75
347
S21
ICPC
Skin texture symptom/complaint
1.5
7.8
239
1615
PB1AT
NOMESCO Finland
Upper extremity artery PTA
45.1
7.7
9
*
L88
ICD-10 Finland
Pyoderma gangrenosum
45.1
7.7
9
*
M01AH02
ATC
rofecoxib; oral
1.5
7.7
267
1852
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
7.7
196
1263
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
7.7
154
928
T90
ICPC
Diabetes non-insulin dependent
1.4
7.7
430
3273
TJF80
NOMESCO Finland
Ostomy education
4.1
7.7
28
69
N03AX09
ATC
lamotrigine; oral
2.1
7.7
84
411
L85.80
ICD-10 Finland
Hudhorn
7.4
7.7
17
23
C02AC05
ATC
moxonidine; oral
2.0
7.6
88
438
JN4BD
NOMESCO Finland
Extensive body CT
1.6
7.6
208
1365
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
2.3
7.6
64
278
N06AX16
ATC
venlafaxine; oral
1.5
7.6
250
1712
SPAT1283
SPAT
Restricted health certificate
1.5
7.6
285
2008
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
8.0
7.6
16
20
L88
ICPC
Rheumatoid/seropositive arthritis
2.1
7.6
79
379
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.5
7.6
59
1149
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
11.9
7.6
13
11
K59.0
ICD-10 Finland
Constipation
1.9
7.5
108
584
L14
ICPC
Leg/thigh symptom/complaint
1.7
7.5
143
850
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.1
7.5
87
432
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.8
7.5
30
80
JF2BB
NOMESCO Finland
Clongraphy with duple contrast
8.9
7.5
15
17
A08
ICPC
Swelling
2.0
7.5
87
433
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.7
7.5
161
992
WYA00
NOMESCO Finland
Screening and health check-up
3.1
7.5
38
123
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
2.7
7.5
48
179
A04AA01
ATC
ondansetron; systemic, rectal
1.8
7.5
135
788
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
7.1
7.5
17
24
U07
ICPC
Urine symptom/complaint other
1.8
7.5
115
638
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.5
7.5
55
221
L29.8
ICD-10 Finland
Other pruritus
4.0
7.5
28
71
D99
ICPC
Disease digestive system other
3.9
7.4
29
76
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
3.9
7.4
29
76
M01AB51
ATC
indometacin, combinations; oral, rectal
2.5
7.4
56
230
TGA30
NOMESCO Finland
Thoracocentesis
4.4
7.4
25
57
Z3231
NOMESCO Finland
Registered nurse
0.7
7.4
312
4153
C07AB07
ATC
bisoprolol; oral
1.3
7.4
930
7957
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
5.0
7.4
22
44
PD4AD
NOMESCO Finland
CT of lower extremity arteries
6.5
7.4
18
28
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
7.7
7.4
16
21
JF1AD
NOMESCO Finland
Small bowel CT
5.3
7.4
21
40
S10
ICPC
Boil/carbuncle
1.9
7.4
105
570
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.9
7.4
28
72
XQ848
NOMESCO Finland
Dermatological photography
2.7
7.4
48
182
A07EC01
ATC
sulfasalazine; oral, rectal
1.7
7.3
153
936
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
7.3
268
1879
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
7.3
64
283
SPAT1240
SPAT
Therapeutic discussion
1.6
7.3
191
1240
Z54.0
ICD-10 Finland
Convalescence following surgery
3.1
7.3
38
125
TUPEI
NOMESCO Finland
NA
0.3
7.3
11
423
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
3.0
7.3
39
131
L98.1
ICD-10 Finland
Factitial dermatitis
+∞
7.3
7
*
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
10.9
7.3
13
12
S06.0
ICD-10 Finland
Concussion
1.6
7.3
184
1182
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.6
7.3
184
1182
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
2.6
7.3
49
190
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
9.4
7.3
14
15
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
9.4
7.3
14
15
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.7
7.3
157
969
PJA10
NOMESCO Finland
Exploration of lymph nodes
3.6
7.3
31
88
1470
FHL
Rectoscopy
4.5
7.3
24
54
TNX39
NOMESCO Finland
Other orthopedic bandage, unspecified region
3.0
7.3
38
126
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
7.2
674
5539
E000003
ATC
NA
2.0
7.2
87
441
SPAT1125
SPAT
Stoma care and guidance
3.0
7.2
39
132
S19
ICPC
Skin injury other
2.1
7.2
76
366
TK820
NOMESCO Finland
Peritoneal dialysis
7.3
7.2
16
22
H53.1
ICD-10 Finland
Subjective visual disturbances
1.8
7.2
120
686
L73.8
ICD-10 Finland
Other specified follicular disorders
4.4
7.1
24
55
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.7
7.1
149
910
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
20.1
7.1
10
5
T82
ICPC
Obesity
2.2
7.1
68
314
N29
ICPC
Neurological sympt/complt other
2.9
7.1
41
143
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.8
7.1
110
611
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.0
7.1
86
438
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.3
7.1
62
275
M23.8
ICD-10 Finland
Other internal derangements of knee
2.1
7.1
72
341
A07EA06
ATC
budesonide; oral, local oral
2.2
7.1
70
329
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.2
7.0
35
112
NBG10
NOMESCO Finland
Acromioplastia
2.3
7.0
62
276
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
10.0
7.0
13
13
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
7.0
239
1652
62660
ICD-8 Finland
Disorders of menstruation, Intermenstrual bleeding
2.2
7.0
69
321
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
2.6
7.0
46
176
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.5
7.0
30
86
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
3.1
7.0
35
113
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
3.6
7.0
29
81
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.6
7.0
173
1109
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.0
7.0
87
448
R15
ICD-10 Finland
Faecal incontinence
2.3
6.9
61
270
G04BD08
ATC
solifenacin; oral
1.7
6.9
134
802
R03BB04
ATC
tiotropium bromide; inhalant
1.6
6.9
182
1183
H25.1
ICD-10 Finland
Senile nuclear cataract
0.7
6.9
279
3739
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.9
6.9
40
140
R74
ICPC
Upper respiratory infection acute
1.3
6.9
498
3940
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
5.8
6.9
18
31
Z96.4
ICD-10 Finland
Presence of endocrine implants
13.8
6.9
11
8
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
13.8
6.9
11
8
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
1.8
6.9
110
618
J01CA08
ATC
pivmecillinam; oral
1.3
6.9
808
6839
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.0
6.9
87
453
SPAT1266
SPAT
Separate instruction to prepare for procedure
2.3
6.9
61
273
C10AA04
ATC
fluvastatin; oral
1.6
6.9
169
1082
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.1
6.8
71
341
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
4.8
6.8
21
44
L71.8
ICD-10 Finland
Other rosacea
3.4
6.8
31
93
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
3.4
6.8
31
93
C44.59
ICD-10 Finland
Malignant tumor of the skin on the trunk other or unspecified histology
8.3
6.8
14
17
R19.5
ICD-10 Finland
Other faecal abnormalities
3.1
6.8
35
115
Z37.0
ICD-10 Finland
Single live birth
0.4
6.8
31
724
61610
ICD-8 Finland
Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female
3.2
6.8
33
104
QXA05
NOMESCO Finland
Skin division, unspecified location
6.7
6.8
16
24
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.9
6.8
96
517
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
4.5
6.8
22
49
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
6.1
6.8
17
28
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
5.3
6.8
19
36
M32
ICD-10 Finland
Systemic lupus erythematosus
40.2
6.8
8
*
L92.1
ICD-10 Finland
Necrobiosis lipoidica, not elsewhere classified
40.2
6.8
8
*
L81.9
ICD-10 Finland
Disorder of pigmentation, unspecified
16.7
6.7
10
6
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
16.7
6.7
10
6
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.9
6.7
90
478
D07AA02
ATC
hydrocortisone; topical
1.5
6.7
238
1656
8113
FHL
Fractional scraping
1.7
6.7
130
778
9734
FHL
Excision and local plastic or associated free skin grafting
4.7
6.7
21
45
L71.9
ICD-10 Finland
Rosacea, unspecified
2.7
6.7
43
160
S12
ICPC
Insect bite/sting
1.7
6.7
148
918
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.7
6.7
130
780
S06
ICPC
Rash localized
1.8
6.7
107
605
R03AA01
ATC
epinephrine; inhalant
22.6
6.7
9
*
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.3
6.7
57
251
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
3.1
6.6
33
106
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
3.0
6.6
36
123
R2110
NOMESCO Finland
Giving the first information
0.5
6.6
41
857
XX2CT
NOMESCO Finland
Other injection with CT guidance
6.4
6.6
16
25
R00.2
ICD-10 Finland
Palpitations
1.7
6.6
136
829
B01AB05
ATC
enoxaparin; parenteral
1.3
6.6
577
4690
FM1CR
NOMESCO Finland
Heart perfusion PET with TT
7.8
6.6
14
18
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
7.8
6.6
14
18
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.9
6.6
89
475
B01AF02
ATC
apixaban; oral
1.6
6.6
174
1134
A10BX04
ATC
[U] exenatide; parenteral
3.5
6.6
28
80
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
6.6
482
3822
ND2BG
NOMESCO Finland
MRI of hand
12.3
6.6
11
9
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
12.3
6.6
11
9
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.6
6.6
175
1140
EB1MA
NOMESCO Finland
Cephalometry with X-ray
2.8
6.6
40
147
K90.0
ICD-10 Finland
Coeliac disease
2.2
6.6
59
266
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
6.6
253
1795
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.1
6.6
69
334
HA1BA
NOMESCO Finland
Extensive X-ray mammography
4.3
6.5
22
51
SPAT1281
SPAT
Other administrative function
1.6
6.5
153
968
J01EA01
ATC
trimethoprim; systemic
1.3
6.5
512
4101
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
2.3
6.5
58
259
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.2
6.5
64
302
L12
ICPC
Hand/finger symptom/complaint
1.5
6.5
256
1824
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
2.1
6.5
71
350
NB6AA
NOMESCO Finland
Humerus X-ray examination
2.6
6.5
43
166
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.3
6.5
58
261
NFQ20
NOMESCO Finland
Amputation of femur
5.3
6.5
18
34
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
5.7
6.4
17
30
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.5
6.4
46
185
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
3.2
6.4
31
98
U14
ICPC
Kidney symptom/complaint
3.2
6.4
31
98
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
2.8
6.4
38
137
J01FA06
ATC
roxithromycin; oral
1.3
6.4
796
6769
N28
ICPC
Limited function/disability (N)
2.9
6.4
37
130
R53
ICD-10 Finland
Malaise and fatigue
1.4
6.4
380
2915
A41.9
ICD-10 Finland
Sepsis, unspecified
2.1
6.4
66
318
M01AH05
ATC
etoricoxib; oral
1.2
6.4
1166
10374
R05
ICPC
Cough
1.3
6.4
412
3203
NGE10
NOMESCO Finland
Incision or suture of capsule of knee joint
3.6
6.4
26
72
L70.0
ICD-10 Finland
Acne vulgaris
2.8
6.4
38
138
R05DA01
ATC
ethylmorphine; oral
1.6
6.4
162
1045
A10BH01
ATC
sitagliptin; oral
1.6
6.4
167
1089
L81
ICPC
Injury musculoskeletal NOS
2.5
6.3
45
179
69282
ICD-8 Finland
Other eczema and dermatitis, E microbis
8.2
6.3
13
16
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
6.3
54
236
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
6.3
302
2231
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.0
6.3
80
415
D09AB01
ATC
zinc bandage without supplements; topical
2.7
6.3
41
155
C09CA06
ATC
candesartan; oral
1.3
6.3
406
3155
UDM02
NOMESCO Finland
Sinoscopy
2.4
6.3
51
217
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
4.2
6.3
22
53
GAC00
NOMESCO Finland
Biopsy of pleura
5.5
6.3
17
31
N05AH04
ATC
quetiapine; oral
1.4
6.3
283
2065
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
6.3
1165
10375
F70
ICPC
Conjunctivitis infectious
2.4
6.3
49
207
G44.2
ICD-10 Finland
Tension-type headache
1.5
6.3
244
1735
QXA99
NOMESCO Finland
Other skin division, biopsy or local destruction, unspecified location
18.1
6.3
9
5
SDA02
NOMESCO Finland
Parodonthologic therapy
1.3
6.3
612
5047
L98.60
ICD-10 Finland
Pseudolymphoma of the skin
+∞
6.3
6
*
WQ025
NOMESCO Finland
NA
+∞
6.3
6
*
L98.69
ICD-10 Finland
Other infiltrative disease of the skin and subcutaneous tissue
+∞
6.3
6
*
L93.1
ICD-10 Finland
Subacute cutaneous lupus erythematosus
+∞
6.3
6
*
JN6PN
NOMESCO Finland
Leucocyte distribution isotope imaging
+∞
6.3
6
*
L98.5
ICD-10 Finland
Mucinosis of skin
+∞
6.3
6
*
S08
ICPC
Skin colour change
1.9
6.2
90
493
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
4.3
6.2
21
49
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.8
6.2
101
574
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
7.0
6.2
14
20
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.8
6.2
97
543
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
3.4
6.2
27
79
SPAT1373
SPAT
Combined screening in early pregnancy
3.4
6.2
27
79
H04AA01
ATC
glucagon; nasal, parenteral
2.6
6.2
41
158
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
3.0
6.2
33
112
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
2.6
6.2
42
165
A23
ICPC
Risk factor NOS
1.7
6.2
132
815
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.7
6.2
40
150
O36.8
ICD-10 Finland
Maternal care for other specified fetal problems
3.5
6.2
26
74
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
6.2
359
2741
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
6.2
97
546
B01AA03
ATC
warfarin; systemic
1.4
6.2
355
2707
H25.0
ICD-10 Finland
Senile incipient cataract
1.7
6.2
120
722
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.3
6.2
53
233
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
6.2
106
615
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.9
6.2
81
428
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
5.3
6.1
17
32
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
2.4
6.1
47
195
I50
ICD-10 Finland
Heart failure
2.3
6.1
53
234
A10AE04
ATC
insulin glargine; parenteral
1.6
6.1
160
1041
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
6.1
328
2473
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.2
6.1
56
255
D07XB05
ATC
dexamethasone, combinations; topical
2.4
6.1
50
215
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
6.1
415
3249
WX290
NOMESCO Finland
Other blockade of nerve
1.3
6.1
800
6841
R52.9
ICD-10 Finland
Pain, unspecified
1.6
6.1
150
959
DAB00
NOMESCO Finland
Excision of lesion of auricle
3.5
6.1
26
75
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
6.1
114
677
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.3
6.1
51
224
XG466
NOMESCO Finland
Sleep oxymetry
2.1
6.1
65
315
L28.0
ICD-10 Finland
Lichen simplex chronicus
3.6
6.1
25
70
XKD00
NOMESCO Finland
Uroflowmetry
1.4
6.1
267
1942
2165A
ICD-9 Finland
Benign neoplasm of skin, Skin of trunk, except scrotum[VARTALON IHON BEN KASVAIN,NAEVUS PIGMENTOSUS]
12.5
6.1
10
8
ZZH30
NOMESCO Finland
Bone allograft
12.5
6.1
10
8
G01AF02
ATC
clotrimazole; vaginal
2.0
6.1
74
379
N32.0
ICD-10 Finland
Bladder-neck obstruction
3.9
6.1
23
60
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.7
6.1
24
65
N99.4
ICD-10 Finland
Postprocedural pelvic peritoneal adhesions
3.7
6.1
24
65
PA6AD
NOMESCO Finland
CT of neck arteries
3.1
6.1
30
97
1008
NOMESCO Finland
NA
8.6
6.1
12
14
N41.1
ICD-10 Finland
Chronic prostatitis
2.5
6.1
43
171
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.9
6.0
82
437
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
2.2
6.0
56
258
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
2.8
6.0
35
124
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
6.7
6.0
14
21
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
6.0
329
2489
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
1.7
6.0
125
764
SPAT1043
SPAT
Audiometry
1.5
6.0
197
1350
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
6.0
731
6189
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019225) pH of Specimen
1036
2142
7.52
307.65
6.7
4.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1200
2623
7.83
307.65
5.2
4.5
%
33.3
32.6
1.03
892
1735
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
488
776
7.56
304.04
5.9
3.6
mmol/l
24.7
24.9
0.84
458
720
(3022313) Gas panel - Capillary blood
510
904
6.82
285.83
5.7
3.4
—
—
—
0
0
(3013512) EKG study
1433
6144
4.09
265.61
5.4
3.8
—
—
—
0
0
(3009343) pH of Capillary blood
542
1245
5.27
227.42
5.7
3.4
ph
7.4
7.4
—
10
150
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
544
1258
5.24
226.42
5.7
3.4
kpa
5.1
5.1
0.02
498
1157
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
526
1196
5.29
223.07
5.7
3.4
mmol/l
0.8
1.9
6.56
433
876
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
434
834
6.08
221.51
2.4
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
403
770
6.04
206.33
1.9
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
199
228
9.39
160.89
1.3
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1030
17055
0.33
159.02
21.0
17.0
%
13.9
13.7
6.08
1012
16661
(3008757) Leukocyte morphology finding [Identifier] in Blood
176
208
9.02
138.65
4.5
3.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
333
770
4.83
135.29
1.4
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1117
17280
0.36
132.37
21.3
17.9
g/l
331.2
332.0
2.03
1102
17150
(3044889) 12 lead EKG panel
825
14575
0.35
128.25
3.7
3.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1027
5045
2.75
126.25
3.1
2.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
308
719
4.74
123.30
5.2
3.1
g/l
0.3
0.3
0.29
118
277
(3025468) Yersinia sp identified in Specimen by Organism specific culture
177
250
7.54
119.94
1.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
178
254
7.46
119.52
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
177
252
7.48
119.08
1.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
176
250
7.49
118.65
1.5
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
183
272
7.18
118.41
2.6
2.2
mg/l
30.7
23.2
0.74
60
63
(3005988) Vibrio sp identified in Specimen by Organism specific culture
176
251
7.46
118.22
1.5
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
175
250
7.45
117.36
1.5
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
436
1367
3.65
116.43
3.3
3.0
e9/l
4.2
4.1
0.37
257
1069
(42870588) Differential panel, method unspecified - Blood
1243
6935
2.56
114.98
8.7
5.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
824
3873
2.68
107.34
1.9
1.7
nmol/l
896.4
1179.8
18.21
588
2894
(3038026) Centromere Ab [Units/volume] in Serum
131
159
8.64
100.72
1.2
1.1
u/ml
7.9
78.4
—
7
8
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
129
155
8.72
99.98
1.2
1.1
u/ml
59.7
67.3
—
12
7
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
129
155
8.72
99.98
1.2
1.1
u/ml
52.6
63.0
0.13
11
13
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
126
148
8.91
99.43
1.2
1.1
u/ml
16.9
4.1
—
9
10
(40768804) Tissue Pathology biopsy report
1350
8391
2.31
90.94
2.8
2.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1285
7830
2.31
90.68
5.0
3.6
ng/l
42.2
109.2
0.59
1007
5381
(3017354) Segmented neutrophils/100 leukocytes in Blood
132
185
7.47
89.81
4.1
3.4
%
58.1
56.9
0.18
107
117
(3044640) Blood type and Crossmatch panel - Blood
1127
6602
2.28
86.10
3.1
2.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
88
77
11.81
85.60
2.3
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
87
76
11.82
84.71
2.3
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
87
76
11.82
84.71
2.3
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1427
9450
2.18
77.55
8.0
5.7
mmol/l
1.2
1.2
16.20
1197
8504
(3019069) Monocytes/100 leukocytes in Blood
1443
9606
2.18
77.26
9.4
6.0
%
8.5
8.6
1.33
1328
8961
(3006504) Eosinophils/100 leukocytes in Blood
1438
9561
2.17
77.22
8.5
5.7
%
2.9
2.8
0.41
1314
8882
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
90
96
9.69
76.31
2.3
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
90
96
9.69
76.31
2.3
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
90
96
9.69
76.31
2.3
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
90
96
9.69
76.31
2.3
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1450
9711
2.16
75.91
7.9
5.6
%
58.2
57.3
2.16
1330
9052
(3002030) Lymphocytes/100 leukocytes in Blood
1464
9860
2.16
75.29
8.9
5.8
%
27.4
27.9
0.90
1329
9154
(3022096) Basophils/100 leukocytes in Blood
1396
9279
2.13
73.70
8.6
5.7
%
0.7
0.7
0.77
1280
8626
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
185
431
4.55
73.39
1.6
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1273
8325
2.07
68.34
7.3
9.2
inr
1.3
1.3
0.21
144
2407
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
995
5945
2.11
68.12
3.6
3.0
ng/l
1903.8
1402.2
2.09
764
5073
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1789
13296
2.19
67.87
4.9
3.0
u/l
53.8
47.4
1.93
1610
12311
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
207
566
3.90
66.23
2.1
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1503
10519
2.06
66.10
8.0
5.7
e9/l
0.2
0.2
0.26
1356
9192
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
79
86
9.45
65.93
1.5
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
79
86
9.45
65.93
1.5
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
167
391
4.50
65.75
1.3
1.2
u/ml
8.1
9.2
—
5
6
(3004809) Band form neutrophils/100 leukocytes in Blood
145
307
4.95
64.52
3.9
3.3
%
1.7
1.4
0.34
120
236
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
536
2561
2.39
62.93
6.0
6.7
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
161
383
4.42
62.07
1.2
1.2
u/ml
2.5
4.9
0.41
14
29
(3013707) Erythrocyte sedimentation rate by Westergren method
1964
15378
2.26
61.96
6.7
4.0
mm/h
13.8
12.4
3.57
1765
14182
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
183
484
4.00
61.26
1.3
1.2
u/ml
2.8
3.9
0.51
30
48
(3006315) Basophils [#/volume] in Blood
1446
10154
2.00
60.87
7.8
5.5
e9/l
0.0
0.0
3.07
1345
8737
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
184
491
3.96
60.83
1.3
1.2
u/ml
7.5
8.0
0.03
42
84
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1472
10423
1.99
60.23
10.9
6.3
mmol/l
1.2
1.2
9.46
1261
8734
(3001604) Monocytes [#/volume] in Blood
1434
10111
1.97
58.83
7.7
5.5
e9/l
0.6
0.6
0.30
1338
8695
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
106
184
5.97
58.65
2.3
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
186
529
3.72
56.07
1.3
1.2
u/ml
16.6
34.2
0.62
12
28
(3019198) Lymphocytes [#/volume] in Blood
1453
10400
1.94
55.76
7.8
5.6
e9/l
1.9
1.9
1.19
1336
9137
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
979
6171
1.96
54.74
2.5
2.1
u/l
207.5
220.9
0.16
907
5754
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2003
16134
2.18
53.75
11.6
7.3
u/l
79.0
78.3
0.23
1850
15124
(3044927) Protein electrophoresis panel - Urine
108
209
5.35
53.20
1.3
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
106
202
5.43
53.10
2.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
80
115
7.15
53.07
1.5
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1259
8702
1.89
52.59
2.7
2.2
nmol/l
78.7
77.8
0.47
1034
7758
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
95
165
5.94
52.51
2.2
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
95
165
5.94
52.51
2.2
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
95
165
5.94
52.51
2.2
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
79
114
7.12
52.22
1.5
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
995
6423
1.91
50.85
3.3
2.5
u/l
55.4
57.8
1.21
888
5914
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
55
52
10.79
50.69
3.4
2.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
856
5263
1.95
50.62
2.6
2.2
mg/l
3.4
3.0
5.96
688
4476
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
306
1242
2.67
50.09
1.7
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1815
14278
1.97
49.39
7.2
4.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
98
186
5.44
49.30
5.2
2.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1234
8596
1.85
49.12
2.3
2.0
pmol/l
104.6
94.5
7.40
700
4389
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
60
67
9.15
49.07
4.3
2.2
u/ml
505.0
3658.7
—
20
10
(3000494) Fungus identified in Specimen by Culture
469
2333
2.24
48.94
1.7
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1461
10778
1.85
47.80
8.0
6.1
umol/l
10.5
11.4
1.30
1359
10189
(3037522) Nuclear Ab [Titer] in Serum
504
2635
2.14
46.18
1.5
1.3
titre
559.5
517.7
0.22
157
539
(3021589) Normoblasts [#/volume] in Blood
553
9124
0.50
45.66
11.6
9.3
e9/l
0.0
0.0
1.09
477
7428
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1342
9782
1.80
44.28
4.2
3.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
445
2270
2.17
43.17
4.9
4.1
u/l
237.9
250.0
0.78
406
2139
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
586
3319
2.00
42.85
2.4
1.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
344
1588
2.35
42.43
5.1
3.5
ng/l
103.3
86.5
2.01
282
1368
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
189
646
3.08
42.37
2.2
2.1
ug/l
289.1
561.0
1.51
174
604
(3032057) Clostridioides difficile [Presence] in Stool
44
41
10.90
40.91
2.6
2.1
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
58
78
7.59
40.78
30.0
23.8
ug/l
95.3
123.5
2.36
48
64
(3003458) Phosphate [Moles/volume] in Serum or Plasma
489
2640
2.06
40.64
9.7
5.0
mmol/l
1.1
1.0
1.12
444
2437
(3007853) Bacteria identified in Skin by Aerobe culture
421
2175
2.12
39.24
2.3
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
350
1680
2.26
39.22
2.9
2.5
e9/l
66.5
70.7
1.75
314
1281
(3042936) Bacteria identified in Isolate by Culture
501
2763
2.02
39.11
2.5
1.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1558
12121
1.75
38.61
5.0
4.5
mmol/l
6.7
6.7
0.25
1472
11300
(3013650) Neutrophils [#/volume] in Blood by Automated count
1539
11947
1.74
38.28
10.5
8.7
e9/l
4.0
4.1
0.46
1417
10400
(3014271) Vancomycin [Susceptibility]
65
106
6.27
38.27
2.8
2.7
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
104
262
4.10
37.09
1.4
1.4
u/l
29.1
28.2
0.09
84
213
(4146454)
96
228
4.34
37.00
2.9
2.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
185
678
2.87
36.55
3.4
2.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
33
25
13.36
34.85
1.8
2.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
304
1448
2.25
34.50
3.5
2.6
g/l
10.0
10.5
1.39
263
1314
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
369
1900
2.10
34.39
2.8
2.2
g/l
0.2
0.2
0.47
337
1770
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
270
1232
2.33
33.88
1.3
1.3
au/ml
39.3
50.6
—
6
55
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
169
620
2.85
33.29
1.5
1.5
titre
80.7
133.8
—
7
26
(3020779) Urea [Moles/volume] in Serum or Plasma
342
1736
2.12
33.01
13.2
6.7
mmol/l
11.0
9.7
2.76
321
1650
(3018418) pH of Serum or Plasma
350
6172
0.50
32.14
5.0
3.8
ph
7.4
7.4
0.02
65
1185
(36660697) Celiac disease serology panel - Serum
314
1561
2.16
31.93
1.3
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
63
121
5.31
31.29
3.1
2.0
e6/l
516.7
722.0
1.65
55
51
(4015189)
42
54
7.89
30.67
2.2
2.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
114
349
3.37
30.60
1.6
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
148
529
2.91
30.56
2.2
1.5
g/l
1.1
1.2
1.84
141
503
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
193
795
2.55
30.24
1.9
1.9
ug/l
1.8
1.7
0.07
149
705
(3031040) Bacteria [#/volume] in Urine by Automated count
1679
13772
1.66
29.99
6.2
4.4
e6/l
8515.9
1981.8
—
7
209
(3023368) Bacteria identified in Blood by Culture
813
5577
1.68
29.83
4.4
4.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
281
1375
2.17
29.66
2.6
2.4
au/ml
11.6
22.9
—
7
71
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
142
513
2.87
28.75
2.2
1.5
g/l
0.2
0.2
1.28
135
488
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
95
271
3.60
28.42
3.8
2.6
u/ml
21087.1
2439.9
0.46
13
19
(3027945) Reticulocytes/100 erythrocytes in Blood
404
2289
1.91
28.36
2.8
2.5
%
1.8
1.8
0.07
326
2018
(3002179) Metamyelocytes/100 leukocytes in Blood
305
1566
2.08
28.36
4.4
3.6
%
1.2
0.6
0.97
119
333
(3004789) Transferrin [Mass/volume] in Serum or Plasma
485
2913
1.82
28.32
3.4
2.3
g/l
2.4
2.3
0.17
433
2695
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
112
357
3.24
28.17
8.0
4.5
iu/ml
527.0
962.7
0.45
31
45
(3022948) Iron [Moles/volume] in Serum or Plasma
515
3163
1.79
27.88
3.4
2.3
umol/l
11.9
13.1
3.56
458
2920
(3026250) Tacrolimus [Mass/volume] in Blood
44
67
6.67
27.67
43.5
29.0
ug/l
6.2
7.3
2.64
39
58
(36304419) Bacteria [Presence] in Urine
315
5527
0.51
27.63
3.8
2.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
455
2700
1.84
27.57
3.4
2.4
%
20.4
22.8
3.65
385
2310
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2157
19123
1.89
27.36
6.2
4.8
mu/l
1.9
2.1
1.04
1865
17432
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
193
833
2.43
27.33
2.3
1.9
u/l
42.2
38.6
1.65
169
732
(3007164) IgA [Mass/volume] in Serum or Plasma
597
3844
1.72
27.32
1.6
1.4
g/l
2.3
2.4
0.53
342
2304
(4035726)
343
1868
1.97
27.00
1.5
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
71
171
4.24
26.90
3.1
2.0
e9/l
1.7
1.1
1.61
14
105
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
58
119
4.97
26.76
1.3
1.4
titre
34.4
69.3
—
9
15
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
75
191
4.02
26.39
1.9
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
410
2388
1.86
26.27
2.9
2.3
ug/g
162.0
128.5
0.98
269
1862
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
199
887
2.35
26.20
1.8
1.8
g/l
1.6
1.5
0.34
173
766
(3049717) Cytology report of Urine Cyto stain
176
745
2.46
25.98
2.9
2.6
—
—
—
0
0
(3048879) Bone marrow aspiration report
39
56
7.06
25.88
1.6
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2180
19489
1.88
25.56
16.3
13.0
ml/min/173m2
77.6
80.1
5.79
1918
16022
(3021960) Folate [Moles/volume] in Serum or Plasma
716
4916
1.64
25.37
1.7
1.5
nmol/l
20.0
20.8
0.59
526
4170
(4024509)
77
207
3.81
25.13
1.9
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
305
1637
1.98
24.94
4.5
3.8
%
0.1
0.1
0.51
127
427
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
278
1447
2.04
24.78
1.9
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
103
338
3.13
24.70
2.3
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
49
93
5.35
24.68
2.3
2.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
472
2922
1.76
24.54
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
144
569
2.62
24.53
1.4
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1147
8849
1.54
24.36
3.6
2.7
ug/l
172.2
123.1
2.14
1003
8162
(3028026) IgM [Mass/volume] in Serum or Plasma
233
1145
2.14
24.19
2.2
1.8
g/l
1.3
1.4
0.78
193
1038
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
36
51
7.15
24.18
1.6
1.5
ug/l
0.4
0.4
0.01
24
32
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
60
138
4.43
24.13
1.4
1.5
u/ml
24.2
18.8
0.34
13
26
(3026493) Urate [Moles/volume] in Serum or Plasma
754
5299
1.60
24.05
3.9
2.5
umol/l
1266.0
5982.6
7.29
630
4576
(3017143) Hepatitis C virus Ab [Presence] in Serum
360
2078
1.85
23.57
2.0
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
312
1723
1.93
23.41
4.5
3.7
%
1.1
0.8
0.53
128
467
(3036481) Cortisol [Moles/volume] in Serum or Plasma
331
1867
1.89
23.28
2.8
2.1
nmol/l
345.9
370.5
1.57
289
1698
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
667
4587
1.62
23.12
1.6
1.7
pmol/l
18164487.1
33193376.7
0.34
512
3799
(3018095) Leukocytes [#/volume] in Urine
488
7259
0.59
23.02
4.3
3.5
e6/l
76.8
115.0
0.74
349
5120
(3030467) Casts [#/volume] in Urine by Automated count
348
5662
0.55
22.96
3.9
3.0
e6/l
0.3
0.5
3.06
269
4264
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
47
93
5.13
22.62
1.3
1.1
u/l
26.4
22.2
0.27
40
64
(3004588) Protein electrophoresis panel - Serum or Plasma
261
1371
2.01
22.61
2.2
2.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
125
483
2.67
22.27
1.5
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
400
6199
0.58
21.87
4.0
3.1
e6/l
63.9
87.3
0.39
327
4758
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
46
92
5.07
21.87
1.3
1.1
u/l
93.5
83.5
0.31
41
67
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1852
16061
1.58
21.73
4.9
4.1
pmol/l
15.2
14.8
8.55
1578
14542
(40761535) Cells panel - Urine sediment
299
1669
1.90
21.65
5.5
3.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
104
378
2.83
20.84
1.5
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
637
4432
1.59
20.66
1.3
1.3
u/ml
1.9
1.5
0.29
90
1171
(3042631) Mycobacterium sp identified in Specimen
83
267
3.18
20.61
3.0
2.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
488
7074
0.62
19.99
2.6
2.8
—
—
—
0
0
(4010399)
261
1432
1.92
19.85
1.4
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
284
4725
0.55
19.76
4.5
3.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1127
8931
1.47
19.52
6.7
4.5
g/l
34.7
35.4
4.21
1013
8286
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
125
516
2.50
19.47
2.7
2.1
mg/l
13.4
11.6
1.23
114
473
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2105
18983
1.66
19.38
7.4
5.7
mmol/mol
40.3
39.7
1.65
1809
17465
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
117
471
2.56
19.21
2.2
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
35
62
5.71
18.99
1.5
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2247
20662
1.81
18.84
23.5
13.7
mg/l
18.5
23.8
14.31
1942
16305
(3037692) Legionella sp identified in Specimen by Organism specific culture
36
68
5.36
18.26
1.6
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
112
457
2.52
17.89
2.3
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
367
2312
1.69
17.46
1.4
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
33
60
5.56
17.43
1.8
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
930
7215
1.46
17.37
3.5
3.3
mmol/l
2.3
2.4
0.61
647
6284
(3009508) Creatinine [Moles/volume] in Urine
845
6438
1.47
17.33
4.3
3.1
mmol/l
6.9
7.3
1.66
662
5389
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
48
121
4.02
17.19
1.2
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
840
6403
1.47
17.14
5.1
3.9
mg/mmol
10.5
8.2
0.83
519
3961
(3019550) Sodium [Moles/volume] in Serum or Plasma
2297
21370
1.85
17.03
24.3
15.9
mmol/l
139.7
139.7
0.02
2209
20810
(3012516) Albumin [Mass/volume] in Urine
803
6085
1.47
16.82
4.4
3.2
mg/l
54.5
310.4
5.73
500
3758
(3000093) Morphology [Interpretation] in Blood Narrative
59
175
3.43
16.73
1.1
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2300
21428
1.84
16.66
24.5
16.0
mmol/l
4.0
4.0
4.83
2202
20837
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
22
8
27.72
16.49
6.0
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2131
19464
1.62
16.47
5.2
3.9
mmol/l
1.3
1.3
0.59
1845
17711
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
28
46
6.14
16.39
1.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
67
219
3.12
16.25
1.7
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
409
2698
1.62
16.16
1.4
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
130
599
2.23
15.82
1.4
1.4
ug/g
284.0
286.8
0.06
72
349
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2183
20105
1.64
15.74
6.5
4.6
mmol/l
6.0
5.9
0.39
1862
18252
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
74
261
2.89
15.73
1.0
1.1
g/l
1.7
1.5
1.45
62
234
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
35
76
4.66
15.17
2.1
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
395
2637
1.59
14.75
31.0
24.8
inr
1.4
1.3
0.39
57
377
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
398
2668
1.58
14.60
1.9
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2335
21984
1.85
14.51
16.2
10.2
u/l
25.5
25.4
0.09
2195
21180
(3026389) Candida sp identified in Specimen by Organism specific culture
71
257
2.81
14.42
1.4
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
40
102
3.97
14.15
1.9
13.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
272
1671
1.70
14.08
2.5
2.7
g/l
66.3
66.5
0.10
216
1521
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
19
24
7.97
14.02
1.5
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
19
24
7.97
14.02
1.5
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
19
24
7.97
14.02
1.5
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
25
43
5.86
13.99
1.3
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
37
90
4.16
13.94
1.1
1.1
u/ml
3.5
9.8
—
7
11
(3025159) Blasts/100 leukocytes in Blood
255
1551
1.72
13.68
4.2
3.8
%
0.0
0.3
0.67
120
365
(40761511) CBC panel - Blood by Automated count
2288
21470
1.72
13.63
23.8
13.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
79
1801
0.42
13.51
6.1
3.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
45
129
3.53
13.49
1.3
1.2
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
18
7
25.88
13.36
1.6
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
36
90
4.04
13.09
1.2
1.1
u/ml
47.4
9.1
—
5
8
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
45
132
3.45
13.04
1.3
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
26
51
5.14
12.68
1.5
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
24
44
5.50
12.59
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
24
44
5.50
12.59
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
24
44
5.50
12.59
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
24
44
5.50
12.59
1.1
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
288
4315
0.62
12.53
3.3
2.5
e6/l
4.6
6.0
2.03
248
3771
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
594
4453
1.44
12.52
1.7
1.8
mg/l
1.0
1.2
1.89
416
3409
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
491
3550
1.48
12.51
1.3
1.3
iu/ml
41.2
37.1
0.18
136
1125
(40758558) Short blood count panel - Blood
372
5270
0.65
12.50
7.6
6.5
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
49
156
3.18
12.48
1.1
1.0
mg/l
309.1
289.2
0.63
41
139
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
213
3428
0.59
12.44
3.1
2.6
e6/l
1.0
1.2
0.84
136
1938
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
122
604
2.07
12.41
2.0
1.6
iu/ml
0.6
10.5
0.46
14
115
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
200
1167
1.78
12.41
1.6
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
41
117
3.55
12.39
1.7
1.6
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
17
22
7.77
12.29
1.5
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
97
442
2.24
12.18
2.0
1.6
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
16
6
26.82
12.04
1.6
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
102
479
2.18
11.90
1.8
1.7
e6/l
11007.6
14446.5
0.52
84
350
(21494815) CD4 cells/100 lymphocytes in Specimen
48
156
3.12
11.83
2.0
1.9
%
24.9
46.7
5.88
21
18
(3005322) IgE [Units/volume] in Serum or Plasma
206
1229
1.74
11.83
1.4
1.2
u/ml
239.3
211.3
0.18
177
1130
(40768446) Kidney Pathology biopsy report
26
55
4.77
11.65
1.9
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
262
3950
0.62
11.62
4.9
3.7
ng/l
326.9
358.4
0.09
180
3071
(3044009) aPTT.lupus sensitive (LA screen)
15
18
8.38
11.49
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
120
609
2.02
11.44
2.2
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
109
534
2.09
11.43
1.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
109
539
2.07
11.15
1.8
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
142
771
1.89
11.13
1.4
1.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
63
246
2.60
11.12
2.1
1.6
%
51.5
59.0
0.76
46
157
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
14
16
8.79
11.12
1.5
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
50
173
2.93
11.09
1.4
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
23
46
5.04
10.99
1.5
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2160
20180
1.49
10.98
5.8
4.4
mmol/l
1.5
1.5
0.48
1880
18503
(3012095) Magnesium [Moles/volume] in Serum or Plasma
456
3326
1.45
10.97
4.1
3.2
mmol/l
0.8
0.8
0.76
422
3103
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
609
7735
0.72
10.95
4.6
3.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
304
4377
0.65
10.83
5.2
4.0
kg/l
1.0
1.0
0.44
102
653
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2173
20339
1.50
10.81
5.6
4.4
mmol/l
4.6
4.7
2.76
1901
18760
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
66
268
2.50
10.77
1.1
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
105
520
2.06
10.71
1.1
1.2
titre
95.0
89.3
—
8
44
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
206
3228
0.61
10.69
3.3
2.8
e6/l
2.3
2.8
0.47
131
1748
(40758292) HTLV I+II Ab panel - Serum
17
26
6.58
10.63
1.5
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
52
189
2.79
10.56
1.2
1.2
u/l
59.2
54.3
0.18
14
131
(3035350) Ketones [Presence] in Urine by Test strip
835
10057
0.75
10.44
4.2
3.6
estimate
0.0
0.0
0.00
125
1914
(3021601) Nitrite [Presence] in Urine by Test strip
839
10091
0.75
10.36
5.9
4.9
estimate
0.0
0.0
0.50
128
1930
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
462
3415
1.43
10.29
1.3
1.2
u/ml
14.7
12.8
0.17
114
1295
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
16
24
6.70
10.18
1.1
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
104
525
2.02
10.09
1.2
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
38
119
3.23
10.00
1.0
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
271
3937
0.65
10.00
3.0
3.0
mmol/l
2.5
2.5
0.23
243
3478
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
183
1115
1.69
9.75
2.5
2.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
21
44
4.80
9.53
1.4
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
410
5460
0.70
9.52
4.6
3.9
estimate
0.0
0.0
1.08
124
1878
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
44
155
2.87
9.49
1.8
1.6
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
35
108
3.27
9.44
1.0
1.1
ratio
1.0
1.0
—
7
44
(3019174) dRVVT (LA screen)
14
20
7.03
9.29
1.3
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
13
17
7.68
9.28
7.4
5.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
36
116
3.13
9.07
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
36
116
3.13
9.07
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
84
1615
0.50
8.96
3.2
2.7
ml/min/173m2
62.8
66.4
0.38
34
648
(3010813) Leukocytes [#/volume] in Blood
2382
22912
1.73
8.92
33.2
20.5
e9/l
6.9
6.7
1.64
2326
22237
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
86
425
2.06
8.88
1.8
1.7
nmol/l
47.9
41.2
1.08
77
407
(3024731) MCV [Entitic volume]
2381
22903
1.72
8.87
33.0
20.4
fl
91.3
91.1
1.29
2332
22561
(3009261) Glucose [Presence] in Urine by Test strip
864
10207
0.77
8.86
4.3
3.6
estimate
0.0
0.0
0.80
123
1881
(3035941) MCH [Entitic mass]
2381
22904
1.72
8.85
32.9
20.4
pg
30.3
30.3
0.61
2332
22559
(3026361) Erythrocytes [#/volume] in Blood
2381
22905
1.72
8.84
33.1
20.5
e12/l
4.4
4.5
7.28
2326
22236
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
20
43
4.68
8.82
1.5
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2380
22895
1.72
8.80
33.1
20.5
e9/l
252.7
252.0
0.20
2327
22288
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
45
168
2.71
8.74
1.1
1.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2381
22914
1.71
8.70
33.3
20.6
g/l
132.6
134.5
8.41
2335
22571
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
15
25
6.03
8.65
1.1
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
96
499
1.96
8.62
2.6
3.4
mg/l
1.8
1.5
1.87
87
457
(3021788) Differential panel - Synovial fluid
74
350
2.15
8.57
1.8
1.6
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
25
66
3.82
8.51
1.6
1.2
g/l
43.2
38.4
0.87
12
32
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
88
452
1.98
8.19
2.4
3.4
u/ml
77.4
914.9
0.85
78
420
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
21
50
4.23
8.19
1.3
1.2
ug/l
320.5
74.4
—
10
27
(3017446) Testosterone [Moles/volume] in Serum or Plasma
189
1216
1.60
8.15
2.5
2.1
nmol/l
10.5
12.5
2.41
158
1068
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
41
153
2.71
8.00
1.2
1.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
17
7.09
7.99
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
251
1728
1.50
7.99
2.2
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
176
1121
1.61
7.92
1.3
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
25
70
3.60
7.85
1.4
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
19
44
4.34
7.68
5.1
4.8
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
17
36
4.75
7.64
2.8
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
148
2322
0.61
7.61
2.1
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1395
12477
1.26
7.61
3.0
2.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2183
20736
1.40
7.34
5.6
4.9
mmol/l
2.6
2.8
5.85
1897
19008
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
55
248
2.24
7.22
1.3
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
138
2169
0.62
7.15
4.7
3.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
65
315
2.09
7.13
1.3
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
26
80
3.27
7.10
1.6
1.8
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
13
23
5.68
7.06
1.1
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
72
365
2.00
7.01
1.5
1.3
mmol/l
59.9
62.7
0.22
54
290
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
14
27
5.21
6.97
1.1
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
15
31
4.86
6.93
1.7
1.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
33
119
2.80
6.90
1.3
1.4
nmol/l
1.3
1.2
0.03
19
95
(3037556) Urate [Mass/volume] in Serum or Plasma
23
67
3.46
6.84
1.4
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
120
1913
0.61
6.60
2.7
2.3
u/l
36.6
40.4
0.26
103
1642
(3009214) Lutropin [Units/volume] in Serum or Plasma
84
460
1.85
6.53
1.4
1.3
u/l
11.8
10.8
0.28
67
376
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
71
368
1.96
6.51
1.3
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
107
1742
0.60
6.41
5.1
3.4
mmol/l
1.2
1.2
0.04
99
1511
(3026782) Osmolality of Urine
306
4034
0.73
6.38
3.6
2.6
mosm/kgh2o
522.8
547.3
1.26
262
3435
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
45
197
2.31
6.36
2.5
2.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
110
663
1.69
6.19
2.3
3.1
u/ml
0.3
0.4
0.13
62
375
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
106
637
1.69
6.04
1.4
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
118
730
1.65
6.02
1.5
1.7
mg/l
4.7
3.9
0.22
89
520
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
110
1751
0.61
6.02
4.9
3.0
ng/l
207.6
198.1
0.10
100
1584
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
14
31
4.54
5.98
1.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
93
541
1.75
5.96
1.4
1.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
10
16
6.27
5.95
1.2
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
158
1051
1.54
5.95
1.1
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
34
773
0.43
5.86
4.2
3.4
u/ml
4844.5
5400.6
0.03
29
654
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
70
375
1.89
5.86
1.3
1.3
—
11.6
—
0
6
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
20
5.52
5.80
1.1
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
236
1711
1.42
5.76
2.3
2.4
ug/l
5.8
7.0
0.71
160
1508
(3010144) Erythrocytes [#/volume] in Synovial fluid
43
194
2.24
5.70
2.0
1.4
e6/l
89944.9
107132.6
0.07
36
132
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
299
2262
1.37
5.67
3.3
4.1
ug/l
8.2
21.6
1.94
241
1848
(3045414) Leukocytes [Presence] in Urine
146
966
1.54
5.65
1.7
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
52
257
2.04
5.50
1.5
1.4
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
12
25
4.82
5.49
1.7
1.2
mmol/l
6.6
5.8
—
6
14
(44806071)
12
25
4.82
5.49
1.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
93
555
1.70
5.47
1.3
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
56
286
1.98
5.42
1.3
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
41
186
2.22
5.38
1.2
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
48
3.56
5.32
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
256
1909
1.38
5.31
2.3
2.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
14
35
4.02
5.17
2.3
2.2
ug/l
3.8
3.4
—
7
14
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
60
320
1.90
5.13
1.3
1.2
u/l
24.1
35.5
0.97
47
270
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
67
373
1.82
5.03
1.3
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
61
330
1.87
5.01
1.5
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
26
100
2.62
4.89
1.7
1.6
ug/l
7.1
8.6
0.40
26
83
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
20
67
3.00
4.83
1.4
1.5
pmol/l
15.8
13.7
0.56
14
55
(3014051) Protein [Presence] in Urine by Test strip
20
520
0.38
4.81
1.6
2.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
42
202
2.10
4.81
2.1
2.1
umol/l
10.2
8.7
0.14
28
142
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
10
20
5.02
4.77
2.3
2.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
466
5599
0.79
4.75
1.7
1.6
mmol/l
1.4
1.4
0.11
422
4693
(43055514) Macroprolactin [Presence] in Serum or Plasma
13
33
3.95
4.71
1.1
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
179
1284
1.42
4.67
3.1
3.2
pmol/l
4.4
4.5
0.49
148
1139
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
98
622
1.60
4.59
2.2
3.5
ratio
2.1
1.5
0.47
12
52
(46235355) HIV 1 and 2 tests - Meaningful Use set
394
3194
1.28
4.55
2.1
1.8
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
10
21
4.78
4.53
1.9
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
46
235
1.98
4.50
1.4
1.3
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
17
54
3.16
4.48
1.1
1.2
pmol/l
297.1
279.6
0.07
11
40
(3006462) Nitrate [Presence] in Urine
25
99
2.54
4.46
4.8
3.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
100
643
1.58
4.45
2.3
3.5
mg/l
31.5
78.3
1.41
89
532
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
665
5729
1.22
4.44
5.7
5.0
ug/l
2.3
2.9
1.19
579
5111
(3034860) Kappa light chains.free [Mass/volume] in Serum
100
644
1.58
4.42
2.3
3.5
mg/l
59.7
148.9
0.51
88
533
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
17
55
3.11
4.36
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
43
805
0.53
4.34
4.9
4.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
80
1265
0.62
4.31
8.6
9.3
%
93.8
93.9
0.08
80
1258
(3015171) Extractable nuclear Ab [Units/volume] in Serum
108
713
1.54
4.29
1.4
1.2
u/ml
3.5
0.9
—
5
57
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
17
56
3.05
4.24
1.1
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
78
478
1.65
4.23
2.4
3.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
34
159
2.15
4.21
1.4
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
79
1245
0.62
4.20
7.4
7.0
mmol/l
25.0
24.5
0.50
72
1154
(3001556) Androgen free Index in Serum or Plasma
9
13
6.94
4.16
1.1
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
30
135
2.24
4.09
1.8
1.9
%
16.2
13.4
—
6
51
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
10
23
4.36
4.09
1.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
29
129
2.26
4.06
1.1
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
14
42
3.35
4.04
1.0
1.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
35
169
2.09
4.02
1.2
1.1
nmol/l
312.7
380.6
1.16
30
149
(40761539) Cells [Type] in Urine sediment by Light microscopy
17
58
2.94
4.01
1.1
1.1
—
—
—
0
0
(4211845)
26
111
2.36
3.99
4.6
3.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
182
1348
1.38
3.98
1.4
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
25
105
2.39
3.98
1.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
16
53
3.03
3.96
1.1
1.5
mu/l
50.4
62.4
0.15
11
43
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
15
402
0.37
3.92
6.4
3.8
u/ml
34.0
34.8
0.01
15
394
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
19
70
2.73
3.92
1.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
37
185
2.01
3.88
1.2
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
65
389
1.69
3.88
3.0
2.9
umol/l
30.5
35.0
1.21
57
325
(3044290) Cell count panel - Cerebral spinal fluid
66
399
1.67
3.80
1.1
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
11
29
3.81
3.80
2.1
2.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
21
83
2.54
3.80
1.1
1.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
7
8
8.77
3.77
1.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
64
385
1.68
3.76
1.2
1.2
u/ml
36.5
45.9
—
5
36
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
10
25
4.01
3.70
1.3
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
16
5.64
3.65
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
49
277
1.78
3.59
1.2
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
15
51
2.95
3.57
1.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
53
308
1.74
3.54
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
197
0.25
3.52
1.0
1.6
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
10
26
3.86
3.52
1.7
1.3
ng/l
86.2
93.5
—
10
26
(3010421) pH of Blood
28
559
0.50
3.51
3.8
3.9
ph
7.4
7.4
0.23
21
454
(40768795) Lymph node Pathology biopsy report
37
194
1.92
3.43
1.3
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
22
94
2.35
3.41
1.1
1.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
82
539
1.54
3.39
1.2
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
78
507
1.56
3.39
2.8
3.1
mmol/l
24.9
24.8
0.08
69
433
(21494434) Karyotype in Bone marrow
37
195
1.91
3.39
1.2
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
178
2317
0.75
3.38
2.0
1.7
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
19
76
2.51
3.38
1.4
8.5
mg/l
60.2
71.9
0.33
13
56
(3019832) Treponema pallidum Ab [Presence] in Serum
202
1562
1.32
3.37
1.7
1.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
16
59
2.72
3.32
1.1
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
18
71
2.55
3.29
1.0
1.1
ng/l
51.6
686.3
—
5
16
(3028192) IgG subclass 2 [Mass/volume] in Serum
34
176
1.94
3.29
1.5
1.4
g/l
2.6
3.0
0.78
27
123
(3027135) IgG subclass 1 [Mass/volume] in Serum
34
176
1.94
3.29
1.5
1.4
g/l
5.8
7.1
1.77
26
124
(3024139) IgG subclass 3 [Mass/volume] in Serum
34
176
1.94
3.29
1.5
1.4
g/l
0.3
0.4
2.09
27
123
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
15
54
2.79
3.25
1.1
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
23
103
2.24
3.22
1.0
1.3
pmol/l
37.6
51.3
0.39
16
33
(21494755) Public health laboratory ask at order entry panel
121
1658
0.72
3.22
1.4
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
68
435
1.58
3.18
3.8
3.2
nmol/l
0.8
0.8
0.55
39
344
(3012501) Base excess in Blood by calculation
22
460
0.47
3.18
3.9
4.2
mmol/l
3.2
2.5
0.41
13
313
(4034850)
40
693
0.57
3.18
12.8
9.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
49
289
1.71
3.15
2.1
1.7
g/l
1.0
0.9
0.19
32
221
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
31
158
1.97
3.14
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
41
230
1.80
3.12
1.8
1.5
—
—
—
0
0
(4062490)
34
180
1.90
3.10
1.8
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
14
50
2.81
3.08
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
315
0.38
3.07
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
313
0.38
3.03
1.3
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
81
546
1.50
3.02
1.7
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
19
81
2.36
2.98
1.3
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
377
4427
0.83
2.97
4.7
4.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
324
0.40
2.96
1.3
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
69
2.47
2.96
2.7
2.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
240
0.37
2.92
1.4
1.7
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
17
4.72
2.92
1.1
1.1
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
7
13
5.40
2.87
1.4
1.4
ml/s/173m2
0.2
0.8
—
7
8
(1002224) Polysomnography panel
47
757
0.61
2.84
1.1
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
74
1080
0.68
2.83
9.4
10.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
31
556
0.55
2.82
1.1
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
48
291
1.66
2.82
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
34
187
1.83
2.79
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1790
18632
0.86
2.76
15.9
15.1
%
38.2
39.4
3.68
921
13164
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
178
1393
1.30
2.76
1.3
1.2
iu/ml
98.2
152.2
1.14
48
533
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
22
435
0.50
2.75
1.1
1.4
e6/l
90.1
33.3
0.29
16
335
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
27
138
1.97
2.75
1.3
1.2
—
—
—
0
0
(4094501)
31
550
0.56
2.73
1.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
717
6450
1.16
2.71
3.3
3.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
14
54
2.60
2.70
2.5
1.4
ug/l
14.4
8.6
1.46
14
54
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
60
2.51
2.70
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
481
5471
0.85
2.61
4.0
3.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
54
822
0.65
2.57
1.4
1.3
iu/l
31.6
29.6
0.13
47
708
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
33
185
1.79
2.57
1.2
1.7
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
32
551
0.58
2.55
1.4
2.6
g/l
0.0
0.0
0.00
27
515
(3014148) Varicella zoster virus Ab [Titer] in Serum
37
216
1.72
2.52
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
40
241
1.67
2.44
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
38
226
1.69
2.43
1.4
1.4
e6/l
51590.4
73619.2
0.29
24
132
(3003694) ABO and Rh group [Type] in Blood
498
5618
0.86
2.42
1.4
1.4
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
44
273
1.62
2.41
1.0
1.1
u/ml
8.4
2.4
—
10
114
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
12
5.01
2.40
1.2
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
14
58
2.42
2.37
1.7
1.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
28
155
1.82
2.30
1.1
1.2
u/ml
1.6
1.3
0.08
17
69
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
34
558
0.60
2.28
1.4
2.5
g/l
0.0
0.0
0.00
27
516
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
24
127
1.90
2.26
1.0
1.1
—
—
—
0
0
(40758358) Immune stain study
5
9
5.56
2.21
1.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
198
0.40
2.16
1.1
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
19
3.69
2.15
2.9
5.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
37
227
1.64
2.14
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
78
562
1.40
2.14
1.3
1.3
miu/ml
168.1
216.2
0.70
34
264
(3000330) Specific gravity of Urine by Test strip
79
1078
0.72
2.14
5.2
3.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
9
31
2.91
2.07
2.2
2.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
39
599
0.65
2.00
1.7
2.5
g/l
0.0
0.0
1.42
32
554
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
606
6661
0.88
2.00
3.5
3.1
u/l
36.9
33.6
0.30
557
6316
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
262
2230
1.20
1.97
1.9
1.7
%
1.5
1.5
0.34
221
1936
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
41
619
0.66
1.95
1.6
1.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
34
210
1.63
1.94
1.5
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
27
2.97
1.93
1.1
1.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
193
2313
0.82
1.91
6.4
7.4
kpa
11.4
12.3
2.12
178
2203
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
71
516
1.39
1.89
1.9
1.9
iu/l
4.7
4.6
0.02
27
184
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
156
0.38
1.89
1.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
9
34
2.65
1.86
1.0
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
194
2313
0.83
1.83
6.4
7.4
kpa
5.2
5.1
0.66
177
2200
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
12
4.17
1.82
1.4
4.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
41
270
1.53
1.82
1.2
1.2
u/ml
4.6
4.5
0.02
18
112
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
16
80
2.01
1.80
1.0
1.1
iu/ml
151.8
191.5
0.39
16
80
(40768806) Pleura Pathology biopsy report
34
215
1.59
1.79
1.6
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
29
2.76
1.79
1.4
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
194
2304
0.83
1.76
6.4
7.4
mmol/l
1.0
1.1
0.18
159
1801
(3052851) Hemolysis interference index of Serum or Plasma
42
616
0.68
1.76
4.9
3.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
18
95
1.90
1.75
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
80
1052
0.75
1.74
2.3
1.9
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
18
3.34
1.74
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
412
4601
0.88
1.72
4.1
4.4
%
20.3
21.6
1.09
242
2278
(3003740) Influenza virus B Ag [Presence] in Specimen
42
284
1.49
1.67
1.3
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
17
305
0.55
1.66
2.2
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
77
581
1.34
1.66
2.4
2.1
u/l
1297.7
3222.2
1.17
18
246
(3002523) Influenza virus A Ag [Presence] in Specimen
42
285
1.48
1.64
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
42
605
0.69
1.62
1.1
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
249
0.52
1.59
1.5
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
42
602
0.69
1.58
1.1
1.1
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
6
20
3.00
1.58
1.8
2.0
mg/l
1.1
1.4
—
6
14
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
235
0.51
1.57
1.6
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
21
122
1.73
1.54
1.0
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
25
153
1.64
1.53
1.4
2.1
mmol/l
6.1
6.8
1.25
17
99
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
42
597
0.70
1.52
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
49
350
1.41
1.50
1.2
1.2
u/ml
254.9
258.4
0.03
20
209
(3016750) Collection duration of Urine
5
128
0.39
1.49
2.6
2.1
min
543.4
499.1
—
5
94
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
20
116
1.73
1.48
1.6
1.5
u/field
0.9
2.1
—
10
82
(4306422)
39
268
1.46
1.46
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
378
3393
1.13
1.46
1.5
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
120
0.42
1.37
1.4
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
104
1.74
1.37
1.1
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
123
0.41
1.36
1.0
1.4
—
1.4
—
0
8
(3022621) pH of Urine by Test strip
165
1400
1.19
1.35
3.1
3.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
73
933
0.78
1.35
3.3
2.6
%
1.1
1.2
0.32
73
924
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
42
2.15
1.33
2.0
2.3
umol/l
14.0
18.7
—
9
42
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
52
695
0.74
1.33
1.3
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
21
128
1.65
1.33
2.0
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
56
419
1.34
1.32
1.8
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
24
152
1.58
1.31
1.3
1.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
148
0.47
1.31
1.3
1.5
—
67.8
—
0
13
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
24
2.50
1.30
3.2
1.7
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
8
34
2.36
1.29
3.0
3.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
131
0.46
1.28
1.2
1.7
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
19
115
1.66
1.24
1.4
1.7
mmol/l
7.6
7.8
0.10
14
71
(3011648) Oxygen content in Venous blood
8
159
0.50
1.24
2.8
2.7
%
11.1
10.9
—
8
159
(3004716) Salmonella sp identified in Stool by Organism specific culture
82
1021
0.80
1.24
1.4
1.3
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
13
70
1.86
1.24
2.4
2.6
e6/l
1134.3
623.8
0.50
13
55
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
38
270
1.41
1.23
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
22
139
1.59
1.23
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
37
2.17
1.21
3.0
3.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
55
715
0.76
1.19
1.5
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
31
439
0.70
1.16
2.8
3.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
20
2.50
1.15
4.4
2.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
35
0.00
1.15
0.0
5.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
35
249
1.41
1.14
1.1
1.3
nmol/l
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
308
3408
0.89
1.14
1.4
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
156
0.51
1.13
1.1
1.5
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
30
2.34
1.12
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
111
1.63
1.12
1.1
1.1
—
—
—
0
0
(4281824)
15
245
0.61
1.11
1.7
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
13
73
1.78
1.10
1.1
1.8
umol/l
61.3
183.6
—
7
41
(3002619) Bacteria identified in Specimen by Culture
7
31
2.26
1.10
1.4
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
56
433
1.30
1.10
1.1
1.2
mmol/l
3.6
3.8
0.78
51
405
(3018677) aPTT in Platelet poor plasma by Coagulation assay
336
3053
1.12
1.09
2.5
2.0
s
28.4
29.8
5.49
319
2955
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
30
422
0.71
1.09
1.4
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
22
327
0.67
1.08
2.0
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
160
1386
1.16
1.07
1.2
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
74
1.76
1.06
1.2
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
53
410
1.30
1.05
2.6
1.7
nmol/l
1.0
0.9
0.37
33
335
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
5
22
2.28
1.03
1.4
2.6
—
1.4
—
0
14
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
60
1.84
1.02
1.2
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
30
416
0.72
1.02
2.3
2.5
%
15.7
16.1
0.24
18
203
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
358
0.70
1.02
1.3
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
5
107
0.47
1.01
1.4
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
176
0.57
1.00
2.2
2.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
28
199
1.41
0.95
1.0
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
32
233
1.38
0.95
1.1
1.0
u/ml
0.8
2.3
1.45
11
84
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
28
2.15
0.91
1.0
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
182
2046
0.88
0.91
6.5
7.8
%
94.0
95.6
1.92
175
1971
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
155
0.58
0.88
1.0
1.5
umol/l
12.3
12.9
—
9
147
(3000991) Gas panel - Venous blood
146
1657
0.87
0.85
8.8
8.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
31
1.94
0.84
3.2
3.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
113
0.53
0.83
2.7
2.1
—
—
—
0
0
(4268621)
25
180
1.39
0.82
1.9
2.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
164
0.61
0.80
1.0
1.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
122
1065
1.15
0.79
6.1
9.6
mmol/l
24.4
24.4
0.04
106
1001
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
80
675
1.19
0.79
1.1
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
147
0.61
0.79
1.1
1.1
—
185.6
—
0
27
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
37
474
0.78
0.78
1.7
2.4
ug/min
239.9
103.8
0.54
18
291
(3012565) Volume of 24 hour Urine
5
98
0.51
0.78
4.2
2.7
ml
1505.0
1922.8
—
5
84
(3004451) EKG impression Narrative
5
99
0.50
0.77
1.0
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
27
0.00
0.77
0.0
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
303
0.72
0.77
1.3
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
67
1.64
0.75
1.3
1.8
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
41
1.71
0.70
1.0
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
28
214
1.31
0.66
1.1
1.1
u/ml
1.8
3.7
—
10
82
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
62
1.62
0.65
1.2
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
26
338
0.77
0.65
1.5
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
129
0.62
0.63
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
206
2244
0.91
0.63
1.6
1.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
57
478
1.20
0.63
3.6
3.5
mg/l
23.7
25.4
0.09
16
295
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
33
413
0.80
0.62
1.8
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
33
413
0.80
0.62
1.8
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
27
209
1.30
0.60
2.7
1.3
mosm/kgh2o
280.1
278.4
0.11
20
157
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
21
0.00
0.60
0.0
1.2
—
8.0
—
0
9
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
22
0.00
0.59
0.0
2.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
496
5205
0.94
0.58
3.9
3.7
%
91.4
90.3
0.38
477
5060
(3033799) Differential panel - Peritoneal fluid
10
64
1.56
0.58
2.6
2.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
160
1755
0.91
0.58
5.8
7.1
mmol/l
1.4
1.4
0.23
153
1691
(4027681)
7
112
0.62
0.58
1.3
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
36
1.67
0.56
1.0
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
25
194
1.29
0.55
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
43
357
1.21
0.55
1.1
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
62
1.45
0.53
1.1
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
13
91
1.43
0.53
1.2
1.4
%
—
67.5
—
0
13
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
98
0.61
0.52
1.7
2.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
133
0.68
0.51
2.4
2.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
83
1.45
0.51
1.1
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
31
251
1.24
0.51
4.0
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
34
411
0.82
0.49
2.8
3.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
47
1.49
0.47
1.7
2.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
34
408
0.83
0.46
3.5
3.3
%
59.4
57.3
0.43
34
408
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
182
1691
1.08
0.46
1.4
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
50
1.40
0.45
1.4
2.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
26
210
1.24
0.45
2.0
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
36
302
1.19
0.44
1.1
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
51
1.37
0.44
1.3
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
131
0.69
0.43
1.4
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
101
1111
0.91
0.43
1.3
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
23
284
0.81
0.42
2.6
1.5
nmol/l
0.2
0.3
2.62
18
216
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
32
1.56
0.42
1.4
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
32
267
1.20
0.42
2.6
2.3
u/ml
13.6
21.3
0.18
32
254
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
272
0.81
0.41
1.7
1.5
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
3.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
33
391
0.84
0.41
1.4
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
36
305
1.18
0.40
1.1
1.1
u/ml
2.7
4.7
0.72
14
145
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
17
0.00
0.40
0.0
2.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
33
390
0.84
0.40
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
33
390
0.84
0.40
1.4
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
103
0.68
0.39
2.1
1.9
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
33
389
0.85
0.39
1.4
1.4
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
19
0.00
0.39
0.0
1.7
—
0.1
—
0
13
(3051611) Lipemic interference index of Serum or Plasma
17
213
0.80
0.36
6.1
3.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
23
278
0.83
0.36
1.3
1.2
u/ml
8.5
3.7
0.36
12
90
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
5
78
0.64
0.35
2.0
2.1
ug/l
17.2
120.2
—
5
68
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
80
0.62
0.35
7.6
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
75
826
0.91
0.35
2.0
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
37
426
0.87
0.34
2.1
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
222
0.81
0.34
3.8
3.9
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
62
557
1.12
0.34
2.3
2.4
g/l
3.4
3.7
0.61
56
525
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
45
1.33
0.33
1.5
2.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
46
1.31
0.33
3.0
1.5
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
6
47
1.28
0.32
2.2
1.6
g/l
20.1
27.1
—
6
39
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
790
1.09
0.32
1.7
2.4
g/l
3.7
3.8
0.21
40
571
(44813793)
16
128
1.25
0.32
1.1
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
791
1.09
0.31
1.7
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
791
1.09
0.31
1.7
2.4
g/l
7.8
7.4
0.83
48
601
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
96
0.73
0.31
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
98
0.71
0.30
1.3
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
39
343
1.14
0.30
1.1
1.1
u/ml
0.7
2.1
1.48
14
137
(3035880) pH of Pleural fluid
14
111
1.26
0.30
1.1
1.3
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
7
56
1.25
0.29
1.4
1.3
nmol/l
81.6
111.7
—
7
42
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
7
57
1.23
0.29
1.0
1.2
%
—
12.3
—
0
7
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
22
259
0.85
0.28
1.1
1.3
mmol/l
7.2
7.3
0.07
13
187
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
150
0.80
0.27
1.3
1.5
g/l
1.0
1.0
0.15
12
150
(3027944) Amphetamines [Presence] in Urine
53
582
0.91
0.26
2.6
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
94
1006
0.93
0.25
2.0
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
742
1.08
0.25
1.7
2.5
g/l
3.0
3.1
0.34
40
586
(1761482) Bacteria [#/volume] in Urine by Culture
58
531
1.09
0.25
5.9
4.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
21
179
1.17
0.25
1.4
2.2
u/field
0.8
1.9
—
9
68
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
75
1.20
0.25
1.1
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
76
1.18
0.24
1.0
1.1
miu/ml
1254.1
1782.5
—
9
76
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
156
1638
0.95
0.24
1.7
1.7
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
85
0.71
0.24
1.0
2.3
%
163.7
146.3
—
6
79
(3045788) Cell count panel - Pleural fluid
17
201
0.84
0.23
1.3
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
5
38
1.32
0.23
1.0
1.1
u/ml
21.3
44.3
—
5
38
(3010726) Horse dander IgE Ab [Units/volume] in Serum
31
275
1.13
0.23
1.1
1.1
u/ml
0.3
2.1
—
7
65
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
33
368
0.90
0.22
1.1
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
27
304
0.89
0.21
1.1
1.3
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
15
126
1.19
0.21
2.3
2.0
ug/l
0.8
2.1
—
8
110
(3025315) Body weight
0
13
0.00
0.21
0.0
4.0
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.3
—
0
7
(3024891) Influenza virus A+B Ag [Presence] in Specimen
47
511
0.92
0.20
1.4
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
0
14
0.00
0.20
0.0
1.6
—
14.4
—
0
8
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
9
111
0.81
0.20
1.0
1.4
mmol/l
5.2
5.9
—
9
104
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
49
1.23
0.20
1.0
1.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
221
2287
0.96
0.20
2.8
2.6
umol/l
11.1
8.3
0.56
190
1978
(3033705) Calcium.ionized [Moles/volume] in Venous blood
28
250
1.12
0.19
2.9
2.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
14
118
1.19
0.19
6.7
4.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
23
203
1.13
0.19
1.0
1.0
u/ml
0.1
0.4
—
5
54
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
109
1.19
0.18
1.2
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
217
0.87
0.18
1.7
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
63
591
1.07
0.17
3.0
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
68
1.18
0.16
1.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
63
593
1.06
0.16
3.0
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
21
187
1.12
0.15
1.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
76
0.79
0.15
1.3
1.7
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
79
0.76
0.15
4.3
2.4
—
—
—
0
0
(3036489) Thrombin time
68
718
0.95
0.15
1.9
2.0
s
22.2
21.5
0.25
45
632
(3000764) Benzodiazepines [Presence] in Urine
62
586
1.06
0.14
3.0
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
33
304
1.09
0.14
1.5
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
48
450
1.07
0.14
3.5
3.1
kpa
8.2
8.1
0.27
42
406
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
59
624
0.94
0.14
1.4
2.4
g/l
36.9
37.7
0.42
33
542
(3008401) Mugwort IgE Ab [Units/volume] in Serum
32
295
1.09
0.14
1.1
1.1
u/ml
0.3
1.5
1.32
12
126
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
122
1.15
0.13
1.0
1.1
u/l
1.0
1.2
—
5
65
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
71
676
1.05
0.13
1.6
2.6
g/l
1.0
1.0
0.03
46
595
(40768800) Prostate Pathology biopsy report
35
376
0.93
0.13
1.2
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
45
478
0.94
0.12
1.6
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
42
394
1.07
0.12
5.8
2.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
35
375
0.93
0.12
2.8
2.6
—
—
—
0
0
(3000492) Spirometry study
187
1916
0.97
0.11
1.6
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
179
1834
0.97
0.11
5.2
3.4
mmol/l
1.6
2.0
1.08
149
1476
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
10
115
0.87
0.10
1.0
1.2
u/l
67.9
77.7
—
10
99
(3021901) Oxygen saturation in Capillary blood
34
362
0.94
0.10
2.8
2.8
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
45
1.11
0.09
1.4
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
12
106
1.13
0.09
2.3
2.4
—
33.8
—
0
7
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
46
1.09
0.09
1.6
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
128
1314
0.97
0.09
4.3
4.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
47
448
1.05
0.09
1.7
2.2
g/l
128.7
129.4
0.05
23
322
(3023511) Choriogonadotropin [Units/volume] in Urine
30
319
0.94
0.09
1.4
1.2
—
—
—
0
0
(4198724)
6
54
1.11
0.09
1.8
1.6
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
6
58
1.03
0.08
2.5
1.8
%
34.2
27.1
—
6
52
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
61
588
1.04
0.08
2.7
2.1
%
96.1
91.0
1.18
54
546
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
7
68
1.03
0.07
3.7
2.2
nmol/l
106.6
144.3
—
7
58
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
733
0.97
0.07
1.6
2.5
g/l
9.8
10.2
0.36
45
629
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
74
0.81
0.07
1.0
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
47
451
1.04
0.07
3.1
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
88
1.02
0.07
6.4
3.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
94
0.85
0.06
2.5
2.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
105
0.86
0.06
1.6
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
105
0.86
0.06
1.3
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
96
941
1.02
0.05
5.4
3.7
mmol/l
23.7
24.2
0.91
85
849
(3023419) Bacteria identified in Sputum by Culture
27
258
1.05
0.04
5.2
2.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
28
292
0.96
0.04
6.7
5.3
umol/l
374.4
368.9
0.06
21
253
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
15
140
1.07
0.04
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
15
140
1.07
0.04
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
15
140
1.07
0.04
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
56
546
1.03
0.04
3.3
1.6
—
—
—
0
0
(3012544) pH of Venous blood
192
1900
1.01
0.04
5.0
3.4
—
7.4
—
0
8
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
117
1182
0.99
0.02
2.4
3.6
u/ml
85.2
62.6
0.28
111
1143
(3006653) Thiamine [Moles/volume] in Blood
11
103
1.07
0.02
1.3
1.2
nmol/l
137.2
132.9
0.13
11
103
(3021447) Carbon dioxide [Partial pressure] in Venous blood
183
1840
0.99
0.01
5.1
3.4
kpa
5.9
5.8
0.16
174
1788
(44790049)
23
224
1.03
0.00
1.8
1.4
—
—
—
0
0
(44806118)
23
224
1.03
0.00
1.8
1.4
—
—
—
0
0
(44790047)
23
224
1.03
0.00
1.8
1.4
—
—
—
0
0
(44790048)
23
224
1.03
0.00
1.8
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
33
336
0.98
0.00
1.1
1.1
iu/ml
28.3
59.9
—
9
72
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
125
0.96
0.00
3.8
6.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
27
265
1.02
0.00
1.1
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
30
299
1.00
0.00
1.1
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
150
1495
1.00
0.00
5.0
3.0
kpa
5.4
4.5
2.90
142
1446
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
11
106
1.04
0.00
24.2
13.5
nmol/l
812.7
863.3
0.13
11
100
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
116
1.03
0.00
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
138
1.01
0.00
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
138
1.01
0.00
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
138
1.01
0.00
1.1
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
335
3347
1.00
0.00
3.6
3.1
ug/l
0.7
0.8
0.49
238
2249
(3044941) Cell count panel - Synovial fluid
31
313
0.99
0.00
1.5
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
10
97
1.03
0.00
2.6
1.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
58
0.86
0.00
2.0
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
58
0.86
0.00
2.0
2.6
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
13.5
—
0
8
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
67
0.90
0.00
1.2
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
59
1.02
0.00
3.2
1.4
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
259.0
—
0
5
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
85
0.94
0.00
2.1
1.4
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
4.8
—
0
6
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.0
—
389.4
—
0
5
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
13.4
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
64
0.94
0.00
2.0
2.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
96
0.94
0.00
1.0
1.2
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
4.4
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint L12_SKINSUBCUTISNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_SKINSUBCUTISNAS | 1.368 [1.23, 1.52] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.191 |
During the follow-up period (1.1.1998 — 31.12.2019), 1166 out of 6189 females with L12_SKINSUBCUTISNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_SKINSUBCUTISNAS | 1.462 [1.29, 1.65] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.025 |
During the follow-up period (1.1.1998 — 31.12.2019), 1088 out of 4258 males with L12_SKINSUBCUTISNAS died.
Mortality risk
Mortality risk for people of age
years, who have L12_SKINSUBCUTISNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.116% | 0.266% |
| 5 | 0.766% | 1.559% |
| 10 | 1.775% | 4.387% |
| 15 | 3.456% | 8.53% |
| 20 | 6.376% | 14.554% |
Relationships between endpoints
↥Index endpoint: L12_SKINSUBCUTISNAS – Other and unspecified disorders of skin and subcutaneous tissue
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data